|  | | |
|
GSAS Harvard Biotechnology Club Spotlight event: Innovations, Entrepreneurship & Development
|
| Date: |
Thursday March 4, 2010 |
| Description: |
GSAS Harvard Biotechnology Club Spotlight event: Innovations, Entrepreneurship & Development
March 4, 2010 515pm -715pm
Cannon Room, Bldg C, Harvard Medical School
515 - 550 pm: Talk 1: Prof Iqbal Z. Quadir
550 - 625 pm: Talk 2: Dr. Una Ryan
630-645 pm: Q/A Session/panel discussion
645-715 pm: Networking reception with speakers and social enterprise companies [Seeding Labs, SolSolution, etc]
Speakers:
UNA RYAN, OBE, PhD, DSc CEO, Diagnostics For All & Research Professor of Medicine at Boston University School of Medicine
Dr. Ryan is the current CEO of Diagnostics For All and was formerly the President and CEO of AVANT Immunotherapeutics, Inc., a publicly traded biopharmaceutical company developing vaccines. Dr. Ryan is also Research Professor of Medicine at Boston University School of Medicine and serves on its Board of Visitors. She serves on a number of boards including Waltham Technologies Inc., AMRI Global, IQuum, the Business Advisory Board of BIO Ventures for Global Health, the Scientific Advisory Board of Genocea, Inc. Dr. Ryan holds a Ph.D. in Cellular and Molecular Biology from Cambridge University and an Honorary Doctor of Science Degree from Bristol University in 2009. She was a Howard Hughes Investigator, NIH MERIT Awardee and an Established Investigator of the American Heart Association.
Diagnostics for All is a Cambridge based non-profit enterprise fusing biotechnology and microfluidics, dedicated to creating low-cost, easy-to-use, point-of-care diagnostics designed specifically for the 60% of the developing world that lives beyond the reach of urban hospitals and medical infrastructures. Professor George Whitesides and his team at Harvard University have pioneered the technology underlying the devices.
IQBAL Z. QUADIR, Director and Founder, MIT Legatum Center for Development & Entrepreneurship & Professor of Practice, MIT Professor
Iqbal Z. Quadir is the founder and director of the Legatum Center for Development and Entrepreneurship at the Massachusetts Institute of Technology (MIT) and founder of Grameenphone Limited in Bangladesh.
From 2001-2004, Quadir taught at the John F. Kennedy School of Government at Harvard University, focusing on the democratizing effects of technologies in developing countries. In 2005, he moved to MIT where he co-founded the journal Innovations (MIT Press) and founded the Legatum Center for Development and Entrepreneurship. Professor Quadir holds both an MBA and an MA from the Wharton School, University of Pennsylvania, and a BS with honors from Swarthmore College. The
Legatum Center for Development and Entrepreneurship was founded on the belief that economic progress and good governance in low-income countries emerge from entrepreneurship and innovations that empower ordinary citizens. The Center administers programs and convenes events that promote and shape discourse on bottom-up development.
Moderated by: CROCKER SNOW, Jr. Director, Edward R. Murrow Center for Public Diplomacy at Tufts University Fletcher School of Law and Diplomacy
President, The Money Matters Institute (1996-present); President, World Times, Inc (1979-2001); Editor in Chief, The WorldPaper (Boston) (1979-2001); National and Foreign Editor, The Boston Globe (1976-1978); Assistant to the Publisher, The Boston Globe (1976-1978); Chief Foreign Correspondant for East Asia, The Boston Globe (1972-1974); Assistant Managing Editor, The Boston Globe (1970-1971). ~
Presentation will be followed by a networking reception. Food and drinks will be served~
Please RSVP at rsvp@thebiotechclub.org (Appreciated but not required)
Questions?: Contact Shaila Rahman, shaila@thebiotechclub.org To learn more about the Harvard Biotechnology Club, visit our Website: www.thebiotechclub.org |
| File Attachments: |
File (None)
 JPEG(None)
 PDF(None)
|
|
Genentech Day
|
| Date: |
Monday November 9, 2009 |
| Description: |
The GSAS Harvard Biotech Club presents
GENENTECH DAY
Date/Time: November 9, 2009; 11am-2pm
Location: NRB, Rotunda
Tentative agenda: 11am-12:30pm: Genentech presentation/panel. 12:30pm- : Networking lunch
Please RSVP at rsvp@thebiotechclub.org. Space is limited to current Harvard & Harvard hospital-affiliates.
Do you want to know why Genentech has been voted one of the Best Places to Work by The Scientist as well as Top Employer by Science Magazine?
Do you want to learn more about both research-related and business-related job opportunities at Genentech?
Are you curious about how the Roche presence will influence research and culture at Genentech?
Are you looking for a JOB at this leading biotech firm located at sunny California??
Then come to GENENTECH DAY to learn about the company & network with recruiters as well as industry leaders!
As part of Sponsorship event, Genentech leaders in research, commercialization, manufacturing and product development will be coming to the HMS campus for presentation & recruitment. They are extremely excited to meet the Harvard community - and hoping to recruit great talents from here!!
Confirmed speakers include:
William Annett, MBA: Director of Business Information Management (Commercial Management)
William Annett received his MBA from the Harvard Business School. His career has consisted primarily of senior roles in rapid growth situations in the healthcare industry. For the past 6 years Mr. Annett has worked in various positions at Genentech in San Francisco, CA. As Director of Business Information Management he is responsible for Commercial business intelligence, reporting, and liaison with the internal IT organization. At the current time he is very involved in the integration of Genentech and Roche¡¦s Commercial IT solutions and business processes. This role has also included leading the Commercial Blueprint, one of the largest change initiatives in Genentech¡¦s history. This $150 million effort replaced Sales & Marketing¡¦s outdated legacy IT systems and business processes with a fully integrated platform featuring more robust capabilities, greater simplicity and cost efficiency. Prior to this role Mr. Annett was Director R&D Finance at Genentech, and led a group of 16 responsible for a budget in excess of $1 billion supporting the R&D pipeline. Mr. Annett has had extensive experience in entrepreneurial finance and management. He has developed 4 early stage companies, including founding a company, taking it public on NASDAQ and running it for 6 years as CEO. Mr. Annett also played a key role in the turnarounds of four other organizations, three times as Chief Executive. He has served on the Board of Directors of a number of early stage companies.
Deborah Baly, Ph.D: Senior Director, Quality, PT (Manufacturing)
Deborah received her Ph.D. in Nutritional Biochemistry from University of California, Davis and began her career in academia at Rutgers University. Deborah transitioned to industry and held director level positions at Bayer Biotechnology in Berkeley, CA and Exelixis, Inc. in South San Francisco, overseeing cell based validation of novel therapeutic targets for both antibody and small molecule therapeutics. Deborah has over 15 years of biotechnology experience, originally joining Genentech in 1991 as a scientist in the Medicinal Analytical Chemistry (MAC) group working on ELISA and cell based assays to support clinical product development. During her previous tenure at Genentech, Deborah served as assay subteam leader on several project teams, including both Herceptin and Avastin core teams. Since 2004 Deborah has held positions of increasing responsibility in the Quality Bioanalytical Development group, including responsibility for leadership of the Clinical Quality Product Stewards, execution of the quality system activities related to clinical products, such as lot release, product investigations, viral and process validation, devices, and appropriate documentation of processes and specifications. Deborah currently serves as Senior Director Corporate Product Quality Support in Genentech¡¦s Pharma Tech division.
Chudi Ndubaku, Ph.D: Medicinal Chemist, Research and Early Development (Research)
Chudi Ndubaku was born in Enugu, Nigeria. After moving to the United States, he completed his undergraduate studies at the University of California, Berkeley where he received his BS in Chemistry in 2001. He then went on to pursue a Ph.D. in Organic Chemistry at the Massachusetts Institute of Technology in research related to natural product total synthesis. After the completion of his work there in 2006, he joined the Medicinal Chemistry department at Genentech. His research at Genentech has focused on combating different mechanisms that drive cancer proliferation and evasion of apoptosis. He very much enjoys living in the Bay Area and his hobbies include biking, golfing and basketball.
Christine Ryan, MS: Medical Liaison, Medical Affairs (Clinical Affairs)
Christine Ryan completed her undergraduate studies at the State University of New York and her Masters of Science in Nursing from Simmons College in Boston. Christine worked as a Nurse Practitioner in oncology for over ten years. She initially entered the biotech industry as a Patient Care Consultant for Schering Plough and joined Genentech in 2003. Christine¡¦s roles at Genentech have included Oncology Coordinator, a role focused on nursing education related to Genentech products. In that role she was involved in the launch of Tarceva and Avastin. She currently works as a Medical Science Liaison facilitating and managing both sponsored and supported trials as a field based member of the Clinical Science Organization.
Will Smiley: Associate Director, College & Staffing Programs (Recruiting)
Will Smiley is the Associate Director for College and Staffing Programs at Genentech. He is responsible for developing and driving Genentech¡¦s university recruitment strategy that sources talent for Genentech¡¦s intern and co-op programs. Prior to Genentech, Will worked in international development on economic, education and democracy development programs around the globe including five years in Ukraine where he managed Freedom Support Act programs for the US State Department. Will served as a training specialist at USAID and worked with USAID contractors on business development in Washington, DC for four years. Will has a MSc in Organizational Management from the School for International Training in Brattleboro, VT and a BA in Psychology from Humboldt State University in Arcata, CA.
About Genentech: Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions, more than 100 projects in the pipeline and a long term plan for growth. Genentech's mission is to be the leading biotechnology company, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. Genentech is committed to high standards of integrity in contributing to the best interests of patients, the medical profession, employees and communities, and to seeking significant returns to the stockholders, based on the continual pursuit of scientific and operational excellence. Genentech was founded by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. After a fateful meeting in 1976, the two decided to start the first biotechnology company, Genentech.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
HBC Career Fair 2009
|
| Date: |
Wednesday October 7, 2009 |
| Description: |
The GSAS Harvard Biotechnology Club proudly presents Career Fair 2009, at the Harvard Medical School.
Date: Wednesday, Oct 7th, 2009
Time: 1.00-5.00PM
Venue: New Research Building, Harvard Medical School, 77 Avenue Louis Pasteur, Boston (Google Map)
Attending this year's fair are a number of firms representing the sectors of Biotech, Consulting, Patent law and Pharmaceutical.
Visit http://www.thebiotechclub.org/careerfair2009/ for list of companies attending.
In addition there will be a series of 20 min Presentations by recruiting companies over the afternoon, and a Panel Discussion by various industry leaders on growth opportunities in the biotech industry today, employers' perspectives on what makes an attractive candidate, and suggestions for the transition from academia to industry.
*Job applicants/attendees: Please bring resumes/cv's and questions for companies!
*For Harvard-affiliated members attending the career fair: please also bring your Harvard ID.
*For non-Harvard-affiliated members attending the career fair: we will charge $20 for students and $40 for non-students at the door. |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Making the Most of the HBC Club's Career Fair: Resumes and Networking
|
| Date: |
Wednesday September 30, 2009 |
| Description: |
Making the Most of the HBC Club's Career Fair: Resumes and Networking
Time: Wednesday, September 30, 2009. 3-4:30 PM
Location: Warren Alpert Building, Room 341
*Note: Due to space limitations, the workshops will be given priority to Harvard-affiliated members.
Excited about the upcoming Harvard Biotechnology Club Career Fair?
To help you prepare for the career fair, Laura Malisheski of the Office of Career Services for Harvard's Faculty of Arts and Sciences, will present this two-part workshop. In part one, we will discuss the conundrum scientists face... when applying for jobs outside academia, should you submit a CV, a resume, or something in between? Learn how to best organize and present your background and experience for different types of PhD-level nonacademic positions. In part two of the workshop, you will learn how to effectively introduce yourself to potential employers and make the most of your time at the HBC Career ! Fair.
RSVP: If you would like to attend, please send an email to RSVP@thebiotechclub.org with "workshop" in the subject line.
Presented to you by the GSAS Harvard Biotechnology Club (www.thebiotechclub.org) in collaboration with Harvard FAS Office of Career Services- |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Healthcare Consulting Panel Discussion
|
| Date: |
Thursday September 3, 2009 |
| Description: |
Harvard Biotechnology Club and the Consulting Club at MIT
invite you to a
Healthcare Consulting Panel Discussion
featuring
Clarion Healthcare Consulting
Clearview Healthcare Partners
Decision Resources
The Frankel Group
Health Advances
- Discover career opportunities at the intersection of science, technology, healthcare and business strategy
- Unique chance to learn about exclusively healthcare-focused consulting firms and get recruiting tips
- Hear from consultants about how healthcare consulting is distinct from other types of consulting
Time: Sept 3rd Thursday, 5:30 – 7:00pm Location: Room 270 – Building 3 (Entrance on 77 Massachusetts Avenue) MIT, Cambridge http://whereis.mit.edu/map-jpg?zoom=level2¢erx=710029¢ery=495411&oldzoom=level3&map.x=300&map.y=183
HMS M2 shuttle drops off at 77 Massachusetts Avenue. For M2 shuttle schedule : http://www.masco.org/transit/ptsM2_WeekdaySchedule.htm
Registration is not required but highly appreciated. To register and for any questions regarding the event, please email rsvp@thebiotechclub.org
Dinner will be provided.
Panelist Bios
Steven Chao, Partner, ClearView Healthcare Partners
Steven has 10 years of experience in life science strategy consulting following MD/PhD program. He was most recently VP of Leerink Swann Strategic Advisors and prior to that a Manager at McKinsey and Company, where he led strategic and operations engagements in pharmaceuticals, biotechnology, and payer organizations. Steven has published over 20 articles, and was involved in Neuroscience research in the laboratories of Dr. Lawrence Benowitz and Dr. Jonathan Seidman. He received his BA in Biochemistry from Harvard College, and M.D. and Ph.D. in Neuroscience from Harvard Medical School.
Rob Stolper, Principal, Decision Resources
Robert is a Principal with the Consulting group at Decision Resources, where he has extensive experience in pharmaceutical strategy development, product life cycle planning, and market and technology analysis. Mr. Stolper's work includes later-stage clinical development and commercialization opportunity, as well as assessment of innovative drug development strategies, and spans all key therapeutic markets. He recently led an engagement exploring the opportunities and implications of innovative research in cell-based therapeutics for use in academic, commercial, and clinical settings, and developed set of recommendations for a leading global provider of enabling technologies to guide near- and long-term investments. Prior to Decision Resources, Mr. Stolper was a consultant with ISO Healthcare Consulting (part of Monitor Group), where he led product- and franchise-level strategy development engagements. Mr. Stolper received his A.B. in Biochemical Sciences from Harvard University.
Pushwaz Virk, Consultant, The Frankel Group
Pushwaz joined Frankel Group in 2008 as a Consultant. Since joining, he has worked on a variety of corporate, Technology and Commercialization strategy, Portfolio optimization and L,M&A projects including development of strategy for a Fortune 50 life sciences company to identify, evaluate and invest in early stage technologies, landscape assessment for a biologic in EU, development of M&A strategy for a startup etc. Prior to Frankel Group, Pushwaz was a Management Fellow at Harvard University Health Services and Group Health Plan where he worked on strategic and operational projects in Quality, Finance and Information Technology departments. He also conducted research on international healthcare delivery models at Harvard Business School and developed teaching content on medical tourism. Before joining Harvard, Pushwaz was the Business Development manager at HCL Technologies where he setup the life sciences and healthcare practice of the IT services division and medical process outsourcing business in the BPO division. He practiced as a primary care physician and hospital administrator before moving to the industry. Pushwaz has degree in medicine from Dayanand Medical College India, MBA from University of Delhi, and Masters in Public Health specializing in Healthcare Management from Harvard University.
Marie Schiller, Partner, Health Advances
Marie joined Health Advances in 1998 with extensive experience in the biotech industry. In Marie's more than one hundred client projects at Health Advances, she has focused on guiding management through business and scientific analyses regarding product development, market positioning, portfolio optimization, business development, and corporate strategy. Prior to joining Health Advances, Marie worked at ArQule, Inc. as production scientist in combinatorial chemistry, synthesis, and production. She also worked for GelSciences, Inc., as project scientist in Polymeric Drug Delivery Systems. Marie contributes extensive expertise in protein-based therapies, drug delivery systems, and several clinical areas, including diabetes and autoimmune diseases. Her clients range from early-stage biotech companies to large pharmaceutical companies. Marie graduated magna cum laude with a BA in chemistry from the University of Vermont, where she was also inducted into the Phi Beta Kappa honor society.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
XSITE 2009: The Xconomy Summit on Innovation, Technology, and Entrepreneurship at Boston University.
|
| Date: |
Wednesday June 24, 2009 |
| Description: |
High-tech, life-sciences, and energy innovation may well hold the key to the nation's economic health and long-term competitiveness. And as a hotbed of American innovation, New England is poised to become a key driver of economic recovery in the U.S.
This full-day conference will celebrate New England innovation and showcase the panorama of transformative efforts underway in the region in such fields as energy, life sciences, robotics, cloud and mobile computing, and transportation¡Xat universities, startups, and large corporations. At the same time, we plan to challenge New England's innovators to step up and take an even larger role in embracing and shaping the future.
XSITE 2009: The Xconomy Summit on Innovation, Technology, and Entrepreneurship at Boston University
Wednesday, June 24, 2009
8:00 am - 7:00 pm
SPECIAL BONUSES:
The first 50 paid registrants will be invited to a pre-conference party with Xconomy at the Cambridge Brewing Co. on June 10, 5:30-7:30 pm, and will be eligible to win:
* a $500 gift certificate to No. 9 Park restaurant, courtesy of Atlas Venture
* a 16GB iPod Touch and lunch/iPod tutorial with Xconomy chief correspondent Wade Roush at Legal Seafoods in Kendall Square
* breakfast with Xconomy founder and editor in chief Bob Buderi at Henrietta's Table in Harvard Square and signed copies of his three books
Register now to get a party invite and a chance at the loot: http://xsite2009.eventbrite.com/
CONFIRMED SPEAKERS INCLUDE:
Bob Brown, President, Boston University
Juan Enriquez, Managing Director, Excel Medical Ventures
John Abele, Co-founder, Boston Scientific
Yet-Ming Chiang, Professor of Ceramics, MIT, Co-founder A123Systems
Jeff Nick, Senior Vice President, Chief Technology Officer, EMC
Mohamad Ali, Massachusetts Senior State Executive, IBM
John Maraganore, CEO, Alnylam
Reed Sturtevant, Managing Director, Microsoft Startup Labs
Christina Lampe-Onnerud, CEO, Boston Power
Tillman Gerngross, Co-founder, GlycoFi, Co-founder and CEO, Adimab, Professor of Engineering, Dartmouth
Mick Mountz, CEO and Founder, Kiva Systems
John D. Halamka, Chief Information Officer, CareGroup Health System, Chief Information Officer and Dean for Technology, Harvard Medical School
PRELIMINARY AGENDA: www.xconomy.com/boston/xsite-2009-agenda
MORE DETAILS AND LATEST UPDATES: www.XSITE2009.com
SCHEDULE:
Registration: 7:00 am - 8:00 am
Program: 8:00 am - 5:15 pm
Networking reception: 5:15 pm - 7:00 pm
LOCATION:
BU School of Management, 595 Commonwealth Avenue, Boston, MA
REGISTRATION INFORMATION:
Early Bird Registration (ends June 1): $395
Saver Registration (ends June 15): $495
Regular Registration (ends June 23): $595
On-Site Registration: $650
Student Registration (scholarships available through the Stay in MA program): $95
Press Registration: please e-mail xconomy@schwartz-pr.com
Tickets are transferable but not refundable.
REGISTER NOW: www.XSITE2009eventbrite.com |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Forefronts in Bioengineering: Stem Cells, Soft Body Robots, Bio-Optics., hosted by ISPE-Boston
|
| Date: |
Tuesday June 16, 2009 |
| Description: |
On Tuesday, June 16 the ISPE Boston Area Chapter will sponsor an educational program entitled "Forefronts in Bioengineering: Stem Cells, Soft Body Robots, Bio-Optics." The presentation will be followed by a tour of the Advanced Technology Laboratories at Tufts. The program will be held at Tufts Gordon Institute, 200 Boston Avenue, Suite 2400, Medford. A networking reception with hors d'oeuvres will take place before the presentation.
Registration: 5:30-6:00pm. Reception: 5:30-6:30pm. Presentation: 6:30-7:30pm. Tour: 7:30-8:30pm.
Members $45; student members $10; non-members $65.
To register online, visit www.ISPEboston.org/events/. For further information, Contact the ISPE Boston Area Chapter office at ISPE@camihq.com or 781-647-ISPE(4773).
The ISPE Boston Area Chapter is comprised of members from regional life sciences companies as well as service providers and equipment manufacturers that support these manufacturing and research operations.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Choosing a lab, hosted by MASS-AWIS and GWIS
|
| Date: |
Tuesday June 16, 2009 |
| Description: |
Hosted by: AWIS Massachusetts Chapter AND Graduate Women in Science Boston Chapter
Choosing a lab: tips and advice on how to select a graduate or post-doctoral lab and how to get the best out of it once you are there
Please join MASS-AWIS and GWIS for a discussion on choosing a graduate and post-doctoral lab. Choosing the right research lab can be one of the most important decisions of a scientist's professional life. Come to learn about the simple rules for selecting the perfect lab and how to get what you want (and need) from Graduate School once you join a lab. Feel free to bring questions for the Q&A session after the presentations.
Featured speakers:
Joanne Kamens, PhD - Director of Discovery, RXi Pharmaceuticals, Worcester, MA
Sharotka Simon, PhD ¡V Post-doctoral fellow, Brandeis University, M
When: Tuesday, June 16, 2009, 5:30pm ¡V 8:30pm
Where: Harvard School of Dental Medicine, Research and Education Building
190 Longwood Avenue, BOSTON, MA 02115 (http://www.hsdm.harvard.edu/asp-html/)
Opportunity for networking with our speakers & Refreshments will be served
FOR DIRECTIONS AND MORE INFORMATION, REGISTER BEFORE JUNE 11 AT
http://www.acteva.com/booking.cfm?bevaid=182421
$5 for members and students - $10 for non-members
Join AWIS and/or GWIS to save money on events and to support our work! Go to www.mass-awis.org, www.gwisboston.org, or pick-up a membership form at the event.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Massachusetts Life Sciences Innovation Day
|
| Date: |
Wednesday June 3, 2009 |
| Description: |
Massachusetts Life Sciences Innovation Day
“The Survival of the Fittest Life Sciences Companies”
How to survive in the current environment, discover new innovations, identify new markets and raise financing for great products and startups in life sciences in Massachusetts
June 3, 2009
8:00 a.m. - 6:00 p.m.
Sheraton Boston Hotel
The 2nd Massachusetts Life Sciences Innovation Day is the biggest day for life sciences startups and innovation in the State of Massachusetts. Last year this house-full, high-energy, hands-on event brought together legendary speakers and experts to mingle with innovators, post-docs, professors, entrepreneurs, innovators, and venture capitalists. It is the flagship event of life sciences in Massachusetts, jointly and actively put together by all the major organizations that are involved in starting the life sciences startup ecosystem in the Commonwealth.
2009 is the 150th anniversary of the publication of Charles Darwin's On the Origin of Species. As we hope to show you in this program Darwin's theory of evolution may be applied to business and technology development. Alnylam, Genzyme, BiogenIdec, Boston Scientific, Sirtris and Confluent are all companies that have evolved to become major players in the Massachusetts life sciences industry. They all started as basic science theories - in a nurturing environment and with the work of many scientists, engineers and business executives these ideas became new products that have changed global healthcare. At this event we'll talk about how to survive and thrive in both academic and industry research and how to see your ideas be transformed into new products. We'll look at how to Raise money... Change cultures... Chase the best ideas, as well as get a wi! ndow on the future of what's new.
We have an exciting program:
· Listen to fascinating keynote speeches and panels
· Walk around the Innovator's Marketplace where you will find everything you need to start a billion dollar life sciences company
· Meet inventors and entrepreneurs at the poster presentations
· Listen to captivating never-before-discussed panels on the "The Sociobiology of Life Science Cultures" and "Proof of Concept: The Missing Link" where all startup related challenges are explored
· Celebrate the 150th anniversary of "On The Origin of Species" by Charles Darwin" by attending "The Natural Selection of Life Science Start-ups" and "The Evolution of Life Science Technologies"
· Learn from the industry's top investors at the panel "Have the Rules of Getting Investment Changed?"
· Network with the Who's Who of Massachusetts life sciences. Every major stakeholder in the Commonwealth in life sciences is involved in jointly organizing this event - including the major universities, research centers and hospitals
WHO SHOULD ATTEND?
Everyone involved in the life sciences innovation and entrepreneurship ecosystem of MA should attend. This event is designed to inspire researchers, innovators, entrepreneurs, post-docs and graduate students throughout the Commonwealth to take their ideas to commercialization faster - whether it is through management, funding or partnerships. It is an opportunity to meet serial entrepreneurs, venture capitalists, angel investors as well as many top leaders who have created companies or commercialized technologies coming out of laboratories and ideas. The day's event will bring together the Commonwealth's leading researchers and innovators, along with top-tier management of biotech, pharma and medtech companies as well as the key life sciences funding sources including angels, foundations, venture capitalists, grant experts, Federal Government and philanthropists.
WHO WILL YOU MEET?
The day's events will bring together the Commonwealth's leading researchers and innovators, along with top-tier management of biotech, pharma and medtech companies and the key life sciences funding sources including angels, foundations, venture capitalists, grant experts, Federal Government representatives, state elected officials, state program managers, and philanthropists focused on cures. We'll supplement this high-octane group with consultants, lawyers and sector experts who can help you find answers faster.
CONFERENCE FEES
$180 Academics/staff at MATTO member institutions, and Members of MATTO, MBC, Mass MEDIC, TiE, MIT Enterprise Forum, and OPEN.
$225 Non-members
$50 Students and post-docs (ID's will be required at the event)
Research Showcase Poster Presenter - have to apply to present and pay Conference registration fees. Download Poster Presenter Application from the website: http://www.mattcenter.org/malsid2009/home.html
$500 - Innovators' Marketplace Exhibitor (includes two attendees). Service providers will only be allocated space in the exhibit hall if they sponsor the conference - for a listing of sponsorship opportunities please visit our Sponsorship page: http://www.mattcenter.org/malsid2009/sponsorship.html
FOR MORE INFORMATION: Conference Information: http://www.mattcenter.org/malsid2009/home.html
TO REGISTER: Conference Registration: http://register.donahue.umassp.edu/events/one?event%5fid=115949
FOR SPONSORSHIP OPPORTUNITIES
Contact : Abi Barrow, MTTC, at abarrow@umassp.edu
Anupendra Sharma, TiE, at anupendra@yahoo.com
FOR INNOVATORS' MARKETPLACE:
Contact: Pushwaz Virk, Frankel Group, at pushwaz@gmail.com
ABOUT MALSI
Massachusetts Life Sciences Innovation Day has been developed by the Massachusetts Life Sciences Start-up Initiative (MALSI). MALSI is a platform organization that brings together all major public and private entities in the State that are committed to building the next generation of Massachusetts companies. MALSI's mission is to ensure that Massachusetts maintains its lead as the #1 region in the world to start, nurture and grow life sciences companies.
MALSI partners include: Massachusetts Technology Transfer Center, the Massachusetts Biotechnology Council, MassMEDIC, TiE Boston, and several major universities and research hospitals. |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Annual Women in Biotech Panel Discussion
|
| Date: |
Monday June 1, 2009 |
| Description: |
Harvard Biotechnology Club
presents
The Annual Women in Biotechnology Event
Come and meet distinquished women leaders in the biotech industry and learn about their path to success, what they have learned, and how they have balanced their personal lives with their careers. Our stellar group of panelists includes a venture capitalist, patent lawyer, and executive leaders from biotech/pharma companies.
Panelists
Ellen Baron (Partner, Oxford Biosciences)
Carmen Bozic (Vice President, Biogen Idec)
Pamela Stetkiewicz (Executive Director, Novartis)
Ivana Magovcevic-Liebisch (Executive Vice President, Dyax Pharmaceuticals)
Moderated by Pearl Freier, President of Cambridge Biopartners
Refreshments will be served.
Men are invited and encouraged to attend!
This event is free for all Harvard students and Harvard/Harvard hospital affiliated postdoctoral fellows.
For non-Harvard affiliated attendees, registration is $10 to be paid at the door
To register - rsvp@thebiotechclub.org
Visit our website for more event information
www.thebiotechclub.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
INTELLECTUAL PROPERTY & PATENT LAW PANEL DISCUSSION
|
| Date: |
Wednesday April 22, 2009 |
| Description: |
THE HARVARD BIOTECHNOLOGY CLUB
Presents
INTELLECTUAL PROPERTY & PATENT LAW PANEL DISCUSSION
April 22 (Wed), 2009
5:30-7:00 PM
Bray Room, New Research Building,
Harvard Medical School, 77 Ave Louis Pasteur, Boston, MA 02115
Panel 1: Navigating the licensing and patent hurdles involved in bringing a technology to the marketplace.
Pamela D. Ariniello
Associate General Counsel for Intellectual Property
Dana-Farber Cancer Institute
Vivien J. Tannoch-Magin, Ph.D.
Associate
Hamilton, Brook, Smith & Reynolds, P.C.
Panel 2: Patent Law as a career option for Scientists.
Melissa Hunter-Ensor, Ph.D.
Associate
Edwards Angell Palmer & Dodge LLP
Brenda Danek, Ph.D.
Associate
Finnegan
PIZZA AND DRINKS WILL BE SERVED
*OPEN TO HARVARD AFFILIATED MEMBERS*
Questions? Please email shaila@thebiotechclub.org or visit our website, www.thebiotechclub.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Harvard Asia Business Conference
|
| Date: |
Saturday February 14, 2009 |
| Description: |
There will be a Healthcare Panel at the conference, focusing on how Asia can differentiate itself in biotech/pharma/healthcare industries, which may be of interest to you. The moderator & speakers include the following: Stephen Knight, Managing Director of Fidelity Biosciences (US; moderator); Sam Liao, Head of Business Development & Licensing, Asia of Novartis Vaccines & Diagnostics; Tomoko Ohmae, CEO of PRARD Inc. (Japan); Chi-Huey Wong, President of Academia Sinica (Taiwan).
Additionally, there will be biotech/pharma-focused speakers in other panels, including in the Entrpreneurship panel and the VC panel. It is a good opportunity to get to know the biotech/pharma trend of Asia, as well as how this industry interacts with the Asian governments as well as other for- and non-profit businesses.
For all Harvard students and affiliates including postdocs, fellows, and residents: please register for student rate (see below). Please remember to bring your Harvard ID to the conference.
*****************
The Executive Committee of the Asia Business Conference organized by the Harvard Business School, Harvard Law School, and the Harvard Kennedy School of Government would like to invite future leaders who will make an impact in Asia and the rest of the world to this year’s conference. Spanning over 2 days, this year’s conference will be held at the Harvard Business School in Boston on February 14-15, and will feature many leaders in business, government, and the public sector. For participants, the conference will offer unique networking opportunities through a variety of scheduled events.
Please visit www.asiabusinessconference.org for more information and registration details. We look forward to meeting you at the conference. |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
The 6th annual Healthcare Conference
|
| Date: |
Saturday January 17, 2009 |
| Description: |
6th Annual Healthcare Conference, hosted by the HBS Healthcare Club “Changing Times, Endless Opportunities: Healthcare Innovation, Policy, and Financing. January 17, 2009
SAVE THE DATE!
The 6th annual Healthcare Conference:
“Changing Times, Endless Opportunities: Healthcare Innovation, Policy, and Financing”
Saturday, January 17, 2009
Harvard Business School
Please join us for the 6th Annual Healthcare Conference, presented by the Healthcare Club, Student Clubs of HBS.
Panel topics include venture capital and entrepreneurship, phama/biotech, medical device, payor/provider, personalized medicine, and public health/public policy.
Our featured keynote speakers include:
Ron Williams, CEO of Aetna
Scott Gottlieb, Former FDA Deputy Commissioner
Lonnie Smith, CEO of Intuitive Surgical
Registration available December 2nd at: Healthcare Conference Registration.
Thank you, and we look forward to seeing you in January!
Sincerely,
Joanne Chang & Kristin Myers, Conference Co-Chairs
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
MIT Enterprise Forum Innovation Series.
|
| Date: |
Wednesday November 12, 2008 |
| Description: |
MIT Enterprise Forum Innovation Series. November 12th.
When: Wednesday, November 12th from 6 to 8:30 PM
Where: MIT Stata Building Kirsch Auditorium
Students are free with ID
Pre-registration is encouraged
http://www.mitforumcambridge.org/nov.html
Neuroscience Drug Discovery and Development: The Route to Disease-Modifying Therapies
Disorders of the brain, including neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease and psychiatric diseases such as schizophrenia and depression, pose some of the hardest challenges for the biopharmaceutical industry. Join us for a discussion of how the biopharmaceutical industry is addressing these challenges, with guest speakers from the cutting edge of neuroscience drug discovery.
Speakers:
Darryle D. Schoepp, Ph.D., Senior Vice President and Neuroscience Franchise Head, Merck Research Laboratories
Christoph M. Adams, Ph.D., Chief Business Officer, FoldRx Pharmaecuticals, Inc.
Douglas M. Fambrough, Ph.D., General Partner, Oxford Bioscience Partners
Todd Sherer, Ph.D., Vice President Research Programs, The Michael J. Fox Foundation for Parkinson’s Research
Moderator: Skip Irving, Partner and Managing Director, Health Advances LLC
http://www.mitforumcambridge.org/nov.html
Contact person: Regina Young, reginas@mit.edu |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Harvard Biotechnology Club Annual Career Fair
|
| Date: |
Tuesday November 11, 2008 |
| Description: |
Are you curious about career options outside of academia?
Are you currently looking for a job?
Harvard Biotechnology Club presents
2008 Career Fair
November 11th, 1-5pm
3rd Floor Rotunda, New Research Building, HMS
Rotunda, NRB (3rd floor)
1:00 - 5:00pm: Recruiting tables
The career fair features biotech, pharmaceutical, patent law, investment and consulting firms.
Firms are looking to recruit applicants with doctoral/medical (PhD, MD, MPH, postdoctoral fellows, residents) and other healthcare/life science degrees. Applicants are encouraged to bring their resumes. Even if you aren’t on the job market come find out more about potential career paths.
Room 217, NRB (2nd floor)
4:00 - 5:00pm: Panel discussion: Exploring Alternative Career Paths in Industry For Scientists
Panelists:
Roopom Banerjee: Vice President, Leerink Swann & Company, Inc.
Michael J. Belliveau, Ph.D., Partner, Clark & Elbing, LLP
Mike DeRidder, Ph.D., consultant, LEK Consulting
Emily Walsh, Ph.D., Program Manager, Alnylam Pharmaceuticals
Join our speakers in an engaging discussion about career opportunities in industry outside the bench and gain insight into their career paths in consulting, program management, investment banking and law.
Moderated by Pearl Freier of Cambridge BioPartners
***
No registration or RSVP is required for attending the career fair.
For Harvard-affiliated/HMS affiliated hospital members attending the career fair: Please bring your Harvard/Hospital ID.
For non-Harvard-affiliated members attending the career fair: we will charge $10.00 at the door.
For questions, please email us : careerfair@thebiotechclub.org
For more information and list of attending companies, please visit: www.thebiotechclub.org/careerfair2008
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Panel discussion: Exploring Alternative Career Paths in Industry For Scientists
|
| Date: |
Tuesday November 11, 2008 |
| Description: |
Curious about careers in science outside the bench?
Panel discussion: Exploring Alternative Career Paths in Industry For Scientists
November 11th (Tomorrow)
4:00 - 5:00 pm : Room 217 NRB
Join speakers from the biotech industry in an engaging discussion about
career opportunities in industry outside the bench and gain insight into
their career paths in consulting, program management, investment banking and
law.
Panelists:
Roopom Banerjee: Vice President, Leerink Swann & Company, Inc.
Michael J. Belliveau, Ph.D., Partner, Clark & Elbing, LLP
Mike DeRidder, Ph.D., consultant, LEK Consulting
Emily Walsh, Ph.D., Program Manager, Alnylam Pharmaceuticals
Moderated by Pearl Freier of Cambridge BioPartners
Hosted by GSAS Harvard Biotech Club: www.thebiotechclub.org |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Harvard Biotechnology Club's Power Career Workshop, Oct 30th (Thursday), 2008, 2:30-4:30pm
|
| Date: |
Thursday October 30, 2008 |
| Description: |
Harvard Biotechnology Club's Power Career Workshop, Oct 30th (Thursday), 2008, 2:30-4:30pm
Excited about the upcoming Harvard Biotechnology Club Career Fair?
To help you prepare for the Harvard Biotech Club Career Fair on November 11, 2008, Laura Malisheski of the Office of Career Services for Harvard's Faculty of Arts and Sciences, will present two workshops:
CV, Resume, or Something In-Between?
Scientists applying for jobs outside academia are faced with a conundrum... should you submit an academic CV, a one-page resume, or a hybrid of the two? Come to this workshop to learn how best to organize and present your background and experience for different types of PhD-level nonacademic positions.
Thursday October 30
2:30-3:30pm
Warren Alpert Building 341
Networking at the HBC 2008 Career Fair
Not everyone likes to network, but most everyone recognizes that it's an essential part of landing a fantastic job! Come to this workshop to learn how to effectively introduce yourself to potential employers and make the most of the HBC 2008 Career Fair.
Thursday October 30
3:30-4:30pm
Warren Alpert Building 341
RSVP: If you would like to attend either or both of these events, please send an email to RSVP@thebiotechclub.org with "workshop" in the subject line.
Presented to you by the GSAS Harvard Biotech Club www.thebiotechclub.org in collaboration with Harvard FAS Office of Career Services |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Moving Your Career Forward in the Biotech and Pharmaceutical Industries
|
| Date: |
Monday October 27, 2008 |
| Description: |
Moving Your Career Forward in the Biotech and Pharmaceutical Industries This panel discussion will include scientific leaders and human resources staffing executives from companies including Alnylam, Genzyme, Sirtris, and Vertex Pharmaceuticals to discuss growth opportunities in the industry, employers' perspectives on what makes an attractive candidate, and suggestions for transitioning from academia to industry. Q&A period with the audience to follow the discussion .
*Please note – only pre-registered candidates are invited to attend. Please bring your confirmation number with you to the career fair before 12:30pm to attend. Space is limited, so please arrive early to ensure your attendance.
Confirmed panelists:
Rachel Meyers, PhD, Senior Director of RNAi Lead Development, Alnylam Pharmaceuticals Carolyn Churcher, Senior Director Strategic Staffing, Genzyme Corporation Brian M. Gallagher, Jr. PhD, Director of Strategic Development, Sirtris, a GSK company Lisa Anderson, Senior Director Strategic Staffing, Vertex Pharmaceuticals
For more information, please visit
http://www.biospace.com/jobs/career-fair-detail/?CareerFairId=159
Moderated by: Pearl Freier, Cambridge BioPartners
Contact person: June Salvati, customercare@biospace.com |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Harvard Biogen Idec Day
|
| Date: |
Monday October 20, 2008 |
| Description: |
Harvard Biogen Idec Day, Monday October 20th 2008
Ever wondered what it would be like to work for a biotech company?
This is your chance to explore the exciting world of biotechnology and learn more about one of the global leaders in the biotech industry. Founded in 1978, Biogen Idec is a key player in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that treat diseases such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Event Details
Date - Oct 20th, 2008
Time - 12pm - 3pm
Location - Bray Room & Pechet Room - New Research Building, Harvard Medical School
41 Avenue Louis Pasteur, Boston 02115
Biogen Idec
Genetown Cafe - Building 6
12 Cambridge Center
Cambridge
Schedule
12pm-12:45pm : Keynote speech by Al Sandrock (Senior Vice President, Biogen Idec)
The keynote speech will address topics such as what is a Biotech company? Biogen Idec's product pipeline, and an overview of therapeutic research areas at Biogen Idec.
12:45pm-1:30pm : Informal networking lunch
Representatives from Biogen Idec Talent Acquisition group will be present to answer questions.
1:30pm-3pm : Panel Discussion with Q&A led by Ken Rhodes (Vice President, Biogen Idec)
The interactive panel discussion will focus on topics related to careers in biotech including diversity of job opportunities in biotech, skills that prospective employers are looking for in applicants and the contrast between careers in academia and industry. Panel participants will be a mix of seasoned and junior Biogen Idec scientists.
4pm-5pm : Biogen Idec Onsite - Networking Cocktail Hour sponsored by Biogen Idec University Relations
Location - Genetown Cafe (Building 6) - 12 Cambridge Center, Cambridge
Don't miss out on this unique opportunity to visit the Biogen Idec campus and interact with Biogen Idec employees including Harvard alums!
There are limited spaces for the event please RSVP at RSVP@thebiotechclub.org with the subject "Biogen Idec" indicating whether you would like to attend the HMS event, the Biogen Idec onsite event, or both. Please include your name, affiliation and position.
Priority for the Networking Cocktail Hour at Biogen Idec facilities will be given to Harvard-affiliated participants.
Presented to you by the GSAS Harvard Biotech Club
www.thebiotechclub.org |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
The ISPE Boston Area Chapter presents 2008 Product Show
|
| Date: |
Wednesday October 8, 2008 |
| Description: |
The ISPE Boston Area Chapter presents its 2008 Product Show from 12 noon to 8pm at the Gillette Stadium Clubhouse in Foxboro, MA. This event is the biggest one-day gathering of biotech, pharmaceutical and life sciences professionals in the northeast and features educational sessions, 250 exhibitors, career fair, behind-the-scenes tours of the stadium, unlimited networking opportunities, student chapter meeting and a chance to meet special guest, pro football Hall of Famer and former Patriot great, John Hannah. The event - including parking and refreshments - is free for all attendees. For more information and to register online, visit http://www.ispeboston.org/ or call 781 647 ISPE (4773).
The ISPE Boston Area Chapter is comprised of over 1,300 members from regional biopharmaceutical companies as well as service providers and equipment manufacturers that support these manufacturing and research operations.
Should you have any questions, please feel free to contact the ISPE Boston Area Chapter office at ISPE@camihq.com or 781-647-ISPE(4773).
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
StartUp Opportunities in Life Sciences by Lyon Area Economic Development Agency (ADERLY)
|
| Date: |
Tuesday September 23, 2008 |
| Description: |
Join us at the workshop : "StartUp Opportunities in Life Sciences" on Tuesday September 23, 6:30pm
For the full program and to register, or print the invitation attached to this email:
http://www.adgensite-emailing.com/aderly/newsletters/archives/tests/46/2008-07-25_15-39-41.html.
Meet with entrepreneurs, business coaches, representatives of the Lyon bio-cluster to :
- Figure out why and how to start a Tech Venture between the US and France/Europe,
- Get some testimonials by French-American bio entrepreneurs,
- Identify why Lyon ranks #1 in Life Sciences,
- Boost your start-up project with partners, resources and funding opportunities.
- A networking cocktail will follow the workshop.
Hosted at the Genzyme Center, 500 Kendall St, Cambridge on tuesday September 23, from 6:30 to 8:30pm.
Presented by the Lyon Area Economic Development Agency (ADERLY), with the support of the French-American Chamber of Commerce (FACCNE) and the Young Entrepreneurs Initiative (YEi).
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
McKinsey & Company presentation at Harvard, September 18, 2008
|
| Date: |
Thursday September 18, 2008 |
| Description: |
For Ph.D. students, Post-docs, M.D. students, Interns, Residents, Fellows and Masters students (non-M.B.A.)
*Please note that Masters students should have completed their undergraduate degree before July 1, 2005. If you completed your undergraduate degree after this date, visit www.mckinsey.com/usschools to learn more about our Business Analyst opportunities.
Date: Thursday, September 18, 2008
Time: 6:00 pm - 8:00 pm
Location: Sheraton Commander (George Washington Ballroom), 16 Garden Street, Cambridge, MA, 02138
Campus Map: http://www.mapquest.com/maps?address=16+Garden+Street%2C+Cambridge%2C+MA%2C+02138 Presentation Agenda:
6:00 - 6:30 pm Introduction to McKinsey and our work, overview of recruiting steps
6:30 - 6:45 pm Group Q&A
6:45 - 8:00 pm Reception, McKinsey consultants available for small group and individual discussions (refreshments served)
ABOUT MCKINSEY & COMPANY, AND THE HEALTHCARE PRACTICE:
McKinsey and Company is a global management consulting firm with 89 offices in 45 different countries. We work for 93 of the global Fortune 100 companies, 70 of the US Fortune 100 companies, and over 2000 governments, NGOs, and non-profits across a wide variety of industries, functions, and geographies. About half of McKinsey consultants come from non-business backgrounds, and about half of those are MDs or PhDs. Currently, there are over 850 healthcare-focused consultants at McKinsey, twice as many as 10 years ago.
Within healthcare, our work is extremely diverse in nature and ranges from developing pre-clinical drug discovery strategies for biotechnology and pharmaceutical companies, to helping global non-profits and state governments develop their strategic approach to health crises, to helping large medical centers develop best-in-class clinical quality systems.
Our work is global in nature with projects taking place in offices across North America, Asia, the Middle East and Europe. Consultants often find that they have the opportunity to do work in healthcare in countries outside of the United States if they wish.
Healthcare clients we work with include:
l Global public health entities: Major non-governmental organizations (e.g., The World Health Organization, The Bill and Melinda Gates Foundation, the Clinton Global Initiative, the United Nations), national governments (including China, UK, , leading public health foundations
l Payor/providers: 20 leading academic medical centers, 7 of the 10 largest US hospital systems, governments (e.g., National Health System in the UK), major pharmacy benefit managers,! and 8 of the top 10 managed care systems
l Private equity funds: 19 of 20 top U.S. private equity firms. Participated in 9 of the top 10 European and 7 of the top 10 U.S. buyout deals since in 2006
l Pharmaceutical, Biotechnology, Device and Diagnostic Companies: 19 of the 20 largest pharmaceutical companies. Most of the major biotechnology, device and diagnostic companies
APPLICATION DEADLINE
Application deadline for permanent positions in offices worldwide: September 28, 2008.
Please visit our website for more information and to apply: www.apd.mckinsey.com
If you will be finished with your studies in 2009 you should apply for a permanent position by the deadline above. Medical interns, residents and fellows finishing in 2010 may also apply now, for a permanent position, to receive an early decision. Those finishing studies in 2010 may apply for an internship by December 7, 2008. All others finishing their program at a later date are welcome to attend and learn more for the future. If you will not be applying now, you may register at the same website; registrants will receive e-mails about upcoming events and opportunities.
Please contact your recruiter should you have questions:
Anu Priyadarshi, Recruiter
McKinsey & Company
anu_priyadarshi@mckinsey.com
www.apd.mckinsey.com |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Women In Biotech Panel Discussion
|
| Date: |
Tuesday May 6, 2008 |
| Description: |
Harvard Biotech Club panel discussion speakers:
Mara Aspinall
President, Genzyme Genetics
Nadine Cohen
Senior Vice-President, Biogen Idec
Panel discussion:
WOMEN IN BIOTECH
Our speakers will talk about their career paths, commercialization of science and the future of biotech/pharma industries.
Tuesday, May 6th
5:00pm - 7:00pm
TMEC amphitheater
260 Longwood Ave., HMS
refreshments/pizza provided
About the speakers:
MARA ASPINALL is the President of Genzyme Genetics. Under Mara's leadership, Genzyme Genetics has expanded its range and reach in the diagnostics marketplace. The division has successfully completed and integrated four acquisitions, expanded research and development programs, and initiated new programs for community outreach and education. Her MBA from Harvard Business School was enriched with the John P. Stevens Prize for leadership. She has served on the board of the HBS Network for Women. A magna cum laude graduate of Tufts University, Mara majored in International Relations.
NADINE COHEN is the Senior Vice President of Regulatory Affairs at Biogen Idec. Dr. Cohen was previously Director of Regulatory Affairs. She joined Biogen in 1999 from the Massachusetts Biologics Laboratories, where she was Senior Director of Quality Control and Technical Services. Prior to that, she was Vice President of Regulatory Affairs and Quality at Alpha Beta Technology, Inc. Dr. Cohen obtained her B.S. in Biology from Rensselaer Polytechnic Institute, and her Ph.D. in Biochemistry from the University of Rochester.
For more information, please visit:
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Technium Challenge International: BPlan competition
|
| Date: |
Friday March 28, 2008 |
| Description: |
GLOBAL BUSINESS COMPETITION OFFERS ENTREPRENEURS
CHANCE TO WIN ONE YEAR’S FREE OFFICE SPACE IN UK INCUBATOR
Sony Corporation Chairman & CEO Howard Stringer To Judge Second Annual Technium Challenge International
American entrepreneurs can gain a foothold into the European market by participating in the second annual Technium Challenge International, a global business planning competition operated by Technium, a network of business incubators, and International Business Wales.
The winner of the contest will earn one year of free office space within one of 10 Technium incubators in Wales, strategic counsel on financing, business planning, technical issues, as well as valuable networking opportunities. Judges include Sony Corporation Chairman and CEO Howard Stringer, a Welshman, as well as Gordon Innes, Director of UK Trade & Investment USA, and Geraint Jones, Chief Executive, Americas, International Business Wales.
“This unique global competition offers a big boost to small businesses seeking resources to grow their business internationally,” said Geraint Jones of International Business Wales. “Wales is an ideal location for companies seeking to gain entrance into the European marketplace, due to our close proximity to London, state-of-the-art telecommunications infrastructure, solid workforce and superior universities.”
U.S. entries must be submitted by March 28, 2008, for review by a local judging panel, where a short list of successful applicants will be selected by early April 2008. These companies will then undergo a final round of judging before the American winner is announced in late April 2008.
Wales’ International Technium Challenge is open to companies from the USA, Australia, New Zealand, China, India, Japan, Korea, South Africa and France. In late May 2008, a representative of the winners from each country, including the USA, will be flown to Wales for a week-long “Learning Journey” that will include one-on-one sessions with U.K. legal and business experts.
Finalists will receive introductions to established business networks, direct guidance on developing a U.K. market entry business plan, as well as detailed briefings about European markets. From there, they will present their business plans in front of the final Technium judging panel, which will determine one overall winner.
Detailed information about the competition including submission deadlines, terms and conditions, and background on last year’s winner is available on the Technium Challenge International website, www.technium.co.uk/challengeinternational.
About Technium
Technium is a network of innovation centers in Wales/UK supporting the growth of technology companies. Technium offers the optimum environment to enable knowledge-based start-up and spin-out companies to realise their potential. Technium includes a network of state-of-the-art facilities across Wales served by the latest information technology and fibre optic bandwidth capabilities. Inside Technium, companies are supported by a team of business and technical support staff and have access to specialist laboratory facilities and communal networking areas. Strong partnerships forged between Technium and local Centres of Research Excellence provide specialist academic support for research & development projects. For more information, visit www.technium.co.uk.
About International Business Wales
International Business Wales is the economic development arm of the Welsh Assembly Government with the responsibility of helping international corporations locate operations in Wales, and with promoting international trade by Welsh businesses. IBW can assist businesses in finding suitable properties in Wales for their operations, help them in finding employees and in obtaining financial assistance from the Welsh government, when appropriate. For more information, visit www.ibwales.com
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
TiE - Boston: The Oncology Revolution Panel Discussion
|
| Date: |
Thursday February 28, 2008 |
| Description: |
TiE - Boston and Harvard Biotech Club invite you to a panel discussion on
"The Oncology Revolution”
Emerging Opportunities in Cancer Therapy and Diagnostics for Entrepreneurs, Investors, Researchers and Students
Oncology is poised to become the biggest therapeutic segment by 2010. As surgery, radiotherapy and drug treatment is leading way to targeted therapies, the next generation of therapeutic and diagnostic interventions are fundamentally transforming the management of cancers. A distinguished panel of experts will share insights about emerging trends in cancer therapeutics and diagnostics. The panel will discuss the opportunities in academia and industry and share their vision of cancer treatment. Two young startups will also showcase their innovations and discuss how they bridged the gap between research and industry.
Panelists
- Mara Aspinall, MBA, President – Genetics, Genzyme
- George D. Demetri, MD, Director, Ludwig Center, Dana-Farber Cancer Institute
- Steven Tregay, PhD, Managing Director, Novartis Venture Funds (Moderator)
- Elan Ezickson, JD, Chief Business Officer, Aveo Pharma
- Janina Longtine, MD, Chief, Molecular Diagnostics, Brigham & Women’s Hospital
- Shuji Ogino, MD, PhD, Deptt. of Molecular Oncologic Pathology, Dana Farber Cancer Institute
Presentations
- Mike Boss, PhD, Xanthus Pharmaceuticals
Venue:
Armenise Amphitheater, Harvard Medical School
210 Longwood Ave, Boston, Massachusetts 02115
Directions: http://hms.harvard.edu/hms/maps.asp
Parking: There is limited street parking. Parking garages are at 300, 333 and 350 - Longwood Ave, Boston, MA 02115
Date:
February 28, 2008; Thursday
Time:
Networking & Dinner 5:30 to 6:30 pm
Panel Discussion 6:30 to 8 pm
Presentations 8 to 8:30 pm
Registration
Please register for this event at: https://www.123signup.com/event?id=txxfx. For more information contact Suchitra (781-272-3875, suchitra@tie-boston.org). Harvard, MIT, Partners Healthcare and Care Group affiliates can RSVP to pushwaz@thebiotechclub.org with their department affiliation, official email id and contact number for free admission. The seating is limited.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Sachs Associates 7th ANNUAL NORTH AMERICA FORUM
|
| Date: |
Monday February 25, 2008 |
| Description: |
7th ANNUAL NORTH AMERICA FORUM
FOR INVESTING & PARTNERING
IN BIOTECH
25 - 26 February 2008, Fairmont Copley Plaza, Boston
Sponsored by:
CBT Advisors | Edwards Angell Palmer & Dodge | Katan Associates | Lexicon Pharmaceuticals
Sachs Associates is a London based company organizing large-scale investor conferences. We hold Biotechnology Forums annually – in Zurich, London and in Boston, to which we invite a selected audience of approx. 400 pharmas, emerging biotechs & investors. The North America Forum is a well established conference going into its 7th year, which focuses on bridging the North American and European Biotech communities
‘The North America Forum’ boasts excellent participation from Europe and the U.S., plus a wider inclusion of regional hotspots. The event is highly transactional, featuring over 60 presentations by a range of early stage to pre-IPO and public life science companies in sector-specific workshops e.g. Therapeutics, Oncology, Medical Device etc. These workshops are interspersed with conference roundtables featuring big pharmaceuticals, investors, tech transfer units etc.
This Forum is designed to bring together all executives in an informal setting for substantive conversations, giving the chance to forge new alliances and partnerships, renew old ones, and secure financing for new initiatives. Presenting at this leading Forum offers a company the opportunity to raise its profile to the larger financial community and provides the chance to communicate face to face with fund managers and advisers. As a result, Sachs Associates events have always provided a fertile ground for million-dollar agreements and ground-breaking partnerships.
Confirmed speakers include:
• Michael F. Bigham, Partner, Abingworth Mangement
• John Maraganore, President & CEO, Alnylam Pharmaceuticals
• Bruce Booth, Principal, Atlas Venture
• Doug Cole, General Partner, Flagship Ventures
• Ansbert Gadicke, General Partner, MPM Capital
• Michael Lytton, General Partner, Oxford Bioscience Partners
• John Brooks, General Partner, Prism VentureWorks
• Lutz Giebel, Managing Partner, SV Life Sciences
• Jens Eckstein, Partner, TVM Capital
For more information, please visit www.sachsforum.com
Working alongside Sachs Associates, GSAS Harvard Biotechnology Club has negotiated discounted fees for our members (only applicable to members who have not already confirmed a slot in Boston).
Should you have any queries, wish to apply as a presenting company, delegate or for complimentary places for institutional investors please contact Abel Jimenez Ramon on +44 (0) 20 7405 5579 or abel@sachsforum.com
To ensure that you qualify for the discounted rate please mention GSAS Harvard Biotechnology Club in your correspondence.
We hope you will join us for what promises to be an exceptional forum for networking, deal-making and discussion.
Kind regards
Sachs Associates
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Life Science and Medical Technology Networking Event
|
| Date: |
Thursday December 6, 2007 |
| Description: |
Harvard students and affiliates are cordially invited to a Life Science and Medical Technology Networking Event in Collaboration with Harvard-MIT Division of Health Sciences and Technology
- Interested in meeting your peers and talking about opportunities in the life sciences and medical technology markets?
- Do you want to start the next great biotech company?
- What is like working for a med tech start-up?
- How does one raise venture capital for a med tech start-up?
Come hear about the experiences and lessons learned from leading entrepreneurs who have successfully started companies spun-out of the HMS, Harvard and MIT communities.
Hosted by:
IDG Ventures, Boston
Speakers:
- Christoph Westphal, co-founder and CEO, Sirtris Pharmaceuticals
- Eugene Chiu, Co-Founder and VP of Business Development, Predictive Biosciences and BEP Alum
- Eric Paley, Co-Founder and CEO, Brontes Technologies (recently acquired by 3M)
- John Santini, President and CEO, MicroCHIPS
- Michael Greeley, General Partner, IDG Ventures Boston
Date & Time:
Thursday, December 6, 2007
5:00-7:00 pm, Drinks and Appetizers
(Remarks begin at 5:30 pm)
Location:
McGovern Institute for Brain Research Building 46-3160
Massachusetts Institute of Technology
77 Massachusetts Ave.
Cambridge, MA 02139
For directions and parking go to: http://web.mit.edu/MCGOVERN/html/Contact_us/contact.shtml
RSVP:
Please RSVP mentioning your name, email, designation and school/hospital affiliation by November 28th by responding to pushwaz@thebiotechclub.org
**space is limited. RSVP required. RSVPs on a first come, first serve basis**
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
New England Venture Summit
|
| Date: |
Tuesday November 27, 2007 |
| Description: |
The New England Venture Summit, presented by youngStartup Ventures, is the premier industry gathering connecting senior executives of early stage and emerging growth companies, venture capitalists, angel investors, technology transfer professionals, university researchers, incubators, successful entrepreneurs and premier service providers.
Whether you are an investor seeking access to new early stage deals, or a CEO or Founder of a new venture looking for funding, visibility and growth, the New England Venture Summit is one event you won’t want to miss.
This exclusive full-day Venture Capital Summit will feature:
25+ Venture Capital Speakers
3 Venture Capital Panels
40 of the Hottest Emerging Companies Seeking Funding
Emerging Company Presentations
High Level Networking Opportunities
A Partial List of Venture Capital Firms Confirmed to Speak:
ABS Ventures
Brook Venture Fund
Castile Ventures
Catalyst Health Ventures
EDF Ventures
Foundation Medical Partners
GrandBanks Capital
Greenhill SAVP, LLC
IDG Ventures Boston
Intel Capital
Norwich Ventures
PureTech Ventures
Rho Ventures
Spark Capital
SV Life Sciences
Thomas Weisel Venture Partners
Tullis-Dickerson & Co., Inc.
Audience Profile: Venture Capitalists, angel investors, corporate VCs, CEOs, CFOs and other senior management of early stage and emerging growth ventures, technology transfer professionals and premium services firms.
http://www.youngstartup.com/newengland07/overview.php
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
13th Nobel-Pauling Thanksgiving Dim Sum Biotech Symposium
|
| Date: |
Thursday November 22, 2007 |
| Description: |
13th Nobel-Pauling Thanksgiving Dim Sum Biotech Symposium
Hosted by: Nobel-Pauling (www.pauling.us)
Sponsors: Merck Research Lab, Boston, HKSTP, IDT, SSTK & Cyagen
Date and time (Nov 22, 2007, 9 am to 3 pm
Themes:
1) If Innovation is a seed, where is the soil?
2) Biotech careers: academia vs. start up vs. biotech vs. big pharma & Biotech careers: USA vs. Europe vs. Asia
3) Sea of Learning: Overview of science parks in HK, Shenzhen, Guangzhou, Shanghai & Beijing, India, Germany & Switzerland
1st Speaker: Dr Grace Wong, CSO, ActoKine Therapeutics, Summary reports of two international conferences
A. The discovery of interferons (50 yrs) Sept, 2007, Oxford, England
B. The Power of One Idea: Clonal Selection Theory (50 yrs, Sir Frank Macfarlane Burnet. The Nobel Prize in 1960, (Pauling is for chemistry, Burnet is for immunology & Darwin is for biology) hosted by WEHI, Oct, 2007, Australia.
Other speakers:
Dr. Zhijian Lu, Wyeth
Dr. Xianlu Qu, Merck Research lab, Boston
Dr Huo Li, BiogenIdec
Dr. Kai Wu, Novartis
Mr. Keven Stevens, IDT
Dr. Stephen Lam, HKSTP, Hong Kong
Mr. Kevin Zhou, SSTK, Shenzhen, China
Mr. Lance Han, Cyagen, Guangzhou, China
Dr. Edmund Tsuei, Roche, Singapore
> 10 speakers from biotech & big pharma
Location(China Pearl, 9 Tyler St, Boston)
Pre-Registration is required at www.pauling.us, fee $ 0. Buffet dim sum
contact: Alex Pauling, alexk at pauling.us
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
WPI Venture Forum - “COOPERATION KEY TO BIOPHARMA GROWTH”
|
| Date: |
Tuesday October 9, 2007 |
| Description: |
What are the characteristics of a successful biotech startup? How can startups and established companies in the biopharmaceutical industry find ways to cooperate? On October 9, 2007, Dr. Rainer Fuchs, Vice President of Biogen Idec and Executive Director of the Biogen Idec Innovation Incubator, Bi3, will examine some of biotech¹s productivity issues and address established and novel models for cooperation between startups and established companies. According to Fuchs, compared with other high-tech industries, the biopharmaceutical industry has yet to establish a culture of "co-opetition” while retaining its reputation as a more prolific source of innovation. He will also discuss whether premoney and seed stage companies are critical to the growth and success of biotech and pharma.
The evening case presentation will be by Joe Straight, President and CEO of Synscia, Inc., a Boston-based biopharmaceutical company commercializing a novel product portfolio in ophthalmology. The company is targeting the chronic diseases of age-related macular degeneration (AMD) and proliferative diabetic retinopathy (PDR), both of which have growing patient populations and represent a market opportunity of $10 billion.
The WPI Venture Forum meeting will be held on Tuesday, October 9, 2007, at the Campus Center - Odeum Room, on the WPI campus in Worcester, MA.
Registration and networking begin at 5:30 p.m. and the meeting begins at 6:30 p.m. Registration cost is $15 for members; and $25 nonmembers. Pre-registration is available online at http://www.wpiventureforum.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Panel Discussion: Should I join a startup?
|
| Date: |
Thursday October 4, 2007 |
| Description: |
"Will I get equity in startups?"
"What if the startup closes down or gets acquired?"
"Which are the hottest startups in Greater Boston area?"
"Do I negotiate for more pay from a startup?"
GSAS Harvard Biotech Club has invited the leading entrepreneurs, VCs and scientists in Boston to share insider information about careers in startups and give tips about how to find that rewarding startup job. The confirmed panelists include
- Humera Fasihuddin, Program Director, Invention to Venture, National Collegiate Inventors & Innovators Alliance
- Eric Furfine, Senior VP of R&D, Adnexus Therapeutics
- Ganesh Venkataraman, CSO, Senior Vice President and Co-Founder, Momenta Pharmaceuticals
- Pooja Pathak, Oxford Bioscience Partners
- Padma Narayan, Principal Scientist, TransForm Pharmaceuticals (J & J)
If you'd like to know more about pros and cons about joining a startup, compensation structures, how to identify a good startup etc. you should attend this event. You'll get a chance to ask questions from people who have developed their careers in startups and have mentored many people who started their career in such roles.
Date: October 4th, 2007
Venue: Cannon Room, Building C, Harvard Medical School, 260 Longwood Ave, Boston
Time: 5 to 7 pm
Please feel free to pass this information to your friends, colleagues. |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Venture Capital Trends and Outlook in Lifesciences: Lessons for Entrepreneurs
|
| Date: |
Thursday September 20, 2007 |
| Description: |
The GSAS Harvard Biotech Club is organizing a panel discussion targeted at researchers and scientists interested in technology commercialization who plan to start their companies.
This is a first of its kind event where two early stage companies will be making a real pitch to four top VCs in front of the audience. You will get a chance to witness what exactly goes on in boardrooms when entrepreneurs raise capital and get an insiders look on how VCs analyze potential investments. The panel will also be discussing recent investments by their firms, discuss what's hot in the Boston Lifescience space and give their perspective of the funding environment.
To attend, please register at
http://www.tie-boston.org/TGS/EM/viewevent/viewEventPT?id_event=1159&from_where=chapter_homepage
If you are a GSAS Harvard Biotech Club member and a Harvard student, please RSVP to pushwaz@thebiotechclub.org for free admission to the event. The RSVPs will be granted on a first-come-first-served basis.
When: Thursday, September 20, 2007, 6:00 PM – 8:30 PM
Where: Cannon Room, Harvard Medical School, 240 Longwood Ave, Boston.
(The Cannon Room is in the link between buildings C-1 and C-2, on the ground floor)
Map: http://www.hms.harvard.edu/about/maps/quadmap.html
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
McKinsey & Company Presentation
|
| Date: |
Tuesday September 18, 2007 |
| Description: |
For Ph.D. students, Post-docs, M.D. students, Interns, Residents, Fellows and Masters students (non-M.B.A.)
Date: Tuesday, September 18
Time: 6:30 pm - 8:30 pm
Location: The Charles Hotel
One Bennett Street
Cambridge, MA 02138
Presentation Agenda:
6:30 - 7:00 pm Introduction to McKinsey and our work, overview of recruiting steps
7:00 - 7:15 pm Group Q&A
7:15 - 8:30 pm Reception, McKinsey consultants available for small group and individual discussions (refreshments served)
APPLICATION DEADLINE
Application deadline for permanent positions in offices worldwide: Sunday, September 30, 2007.
Please visit our website for more information and to apply: www.apd.mckinsey.com
If you will be finished with your studies in 2008 you should apply for a permanent position by the deadline above. Medical interns, residents and fellows finishing in 2009 may also apply now, for a permanent position, to receive an early decision. Those finishing studies in 2009 may apply for an internship by December 9, 2007. If you will not be applying now, you may register at the same website; registrants will receive e-mails about upcoming events and opportunities.
A CAREER WITH McKINSEY & COMPANY
McKinsey & Company is a management consulting firm that advises senior management of the world's leading organizations on issues of strategy, organization, technology and operations. We are always on the lookout for high caliber individuals to help us fulfill our mission: 1) to help our clients make positive, lasting and substantial improvements to their performance, and 2) to build a great firm that is able to attract, develop, excite and retain exceptional people.
People join us from a wide range of disciplines, and you'll find that we're more interested in the quality of your achievements than your particular area of studies. What is most important to us is evidence of success in your chosen field. Working with us, you will gain exposure to a diverse range of industry sectors and business issues that will not only enhance your career options, but also accelerate the pace of your personal development. In addition, you'll be a member of a core team working directly with senior client executives to address the defining business issues of our time.
So, if you like the idea of a career alternative that will stimulate and challenge the very brightest minds together with the opportunity to work with highly motivated colleagues in a supportive, team-based environment, please join us for our presentation.
Also, please visit our website at www.apd.mckinsey.com to learn more about McKinsey & Company. The website features profiles of consultants with backgrounds similar to your own, information about selection criteria, application tips, and the on-line application form.
Please feel free to forward this e-mail to graduate students who might be interested in learning about career opportunities with McKinsey & Company.
Please contact the APD Northeast recruiter should you have questions:
Emily, Recruiter
McKinsey & Company
emily_marquis@mckinsey.com
www.apd.mckinsey.com
OTHER PRESENTATIONS AT HARVARD
Kennedy School of Government
Tuesday, September 25, 6:00 - 8:00 pm
Starr Auditorium, 79 JFK Street
Harvard Business School (First-Years)
Tuesday, November 13, 7:00 - 9:00 pm
The Charles Hotel
Harvard Undergraduate Presentation
Monday, September 24, 6:30 - 9:00 |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Biotech Industry Study Group
|
| Date: |
Wednesday July 18, 2007 |
| Description: |
The Biotech Industry Study Group will hold its first meeting on Wednesday, July 18th at 6PM in the Cannon Room, Building C, HMS campus. Our invited speaker will be Dr. Sandrock, Senior Vice President of Neurology Research and Development at Biogen Idec. We invite you to attend.
The Biotech Industry Study Group (BISG) is a group designed to help graduate students and post-docs considering a career in biotech or pharma learn more about the companies and their research. The meetings will be designed to provide an overview of the company and then, by way of an invited speaker, introduce members to a prominent researcher in the company. Hopefully this will result in the members developing a sense of which company's research and culture provide the best fit and then, when the job search commences, they will already have a contact inside the company.
Alfred W Sandrock, Jr., MD, PhD is Senior Vice President, Medical Research-Neurology at Biogen Idec, Inc. in Cambridge. A board certified neurologist, he leads the team that oversees clinical development in neurologic indications. He is also assistant clinical professor of neurology at Harvard Medical School, and clinical associate in neurology at MGH.
Dr. Sandrock received his MD from HMS and his PhD in neurobiology from Harvard University in Cambridge. He completed an internship in medicine, a residency and chief residency in neurology, and a clinicalfellowship in neuromuscular disease in clinical neurophysiology (electromyography) at MGH.
His contributions to the literature include articles on the identification of molecules that promote axonal regeneration, the role of neuregulin at the neuromuscular junction, as well as multiple articles on therapeutics in multiple sclerosis.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
"How to write a business plan" - an interactive seminar
|
| Date: |
Tuesday May 1, 2007 |
| Description: |
Do you have an idea for a new life science venture? Are you trying to raise money and generate investor interest?
Ian Carver, Executive Director of the Entrepreneurial Services Center, PricewaterhouseCoopers LLP will lead an interactive discussion on successful strategies for crafting a winning business plan for life science start-ups.
Date: Tuesday, May 1st, 2007
Time: 5:30pm-7pm
Location: Cannon Room, C Building, Harvard Medical School Quadrangle
Ian is a director at the Entrepreneurial Services Center within PricewaterhouseCoopers’ Technology, InfoComm and Entertainment (TICE) Practice. His focus is on providing start-up and early-stage technology and life sciences companies with access to informal business advisory services to assist their financing and corporate development initiatives. Services typically include:
• business plan review and critique
• introductions to an extensive network of venture capital and angel investor contacts
• introductions to appropriate banking, investment banking and legal resources
• advice regarding the accounting and tax ramifications of business decisions
• assistance, where feasible, in finding strategic partners within PricewaterhouseCoopers’ lines of business and client network
• access to benchmarking and best practices industry and human resource data to improve company performance and growth
• introductions to potential temporary controller and CFO candidates as well as access to PricewaterhouseCoopers’ Career Services Group to fill a full-time CFO position
• access to audit and tax compliance services specifically designed to meet the needs of early stage, venture backed technology and life sciences companies
Ian has an MBA from the Fuqua School of Business at Duke University and brings over 20 years of operational, general management and business development experience to his position at PricewaterhouseCoopers' Entrepreneurial Services Center.
Refreshments will be served.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
"Getting the right message to the right ears" Seminar Event
|
| Date: |
Wednesday April 25, 2007 |
| Description: |
If you choose a single person in the whole world to be on the other end of the line when the phone rings, and say, "tell me about your product or service," who would that person be? Why? When launching a new product or service, you will need to get the right people to hear your message and react. At the same time, you will have extremely limited time and limited budgets. The speaker will lead a discussion focused on how to get the message to the right people at the right time for the right results. This is will be an interactive presentation and will make use of many real-world examples, including how a small nanotechnology company with a potentially explosive product built a story that outpaced the competition, educated its audiences, and led to a full pipeline.
Speaker Bio:
Nicolas A. Boillot, President, Hart-Boillot, LLC
As co-founder of Hart-Boillot, Mr. Boillot has guided the agency to profitability in every year since it was founded in 1999. In his role as Account Director, he has managed significant communications campaigns for brands such as HP, Gore Bike Wear, EMC, Fairchild Semiconductor, Vicor and NanoHorizons. He has also worked in higher education as a teacher and in finance, where he analyzed European businesses for a group of American investors who sought acquisitions.
Registration is NOT required for this event! To help us out with expected numbers though, please let us know by signing up via this survey (it'll take 5 seconds!).
http://www.surveymonkey.com/s.asp?u=843043685865 |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
French American Innovation Day
|
| Date: |
Monday October 16, 2006 |
| Description: |
Website: http://www.france-science.org/faid/
The Office of Science and Technology of the Embassy of France and Institut
Curie are delighted to invite you to the 5th French-American Innovation Day
(FAID), an event organized yearly in Boston.
The event's goal is twofold:
- to promote research and innovation in areas where our two countries share
a competitive advantage.
- to foster French-American cooperation between laboratories and companies.
This year, it will take place on Monday and Tuesday October 16th and 17th
2006 at the Harvard Medical School in Boston with the participation of H.E.
Jean-David LEVITTE, the Ambassador of France to the US and Mina Bissell,
Ph.D., Distinguished Scientist, UC Berkeley.
The aim of the event is to show the more recent contributions and the
perspectives
of imaging in research and clinical practice with a focus on Cancer
Several aspects will be presented such as the phenotypic screening with the
aim of
developing tailored treatments for cancer patients, the imagining in vivo
immune response,
the development of pathogens-based technology for immuno-therapy
treatment of cancer, elasticity imaging for breast cancer diagnosis and the
most recent
achievements in the field of proton and carbon therapy.
Networking opportunities will be offered during the two-day event for
attendees
to meet new partners in laboratories and companies.
Registration is free but mandatory (limited seating). For further
information, please check our website at www.france-science.org/faid/
Contacts
- Jean-Jacques PIERRAT, Office for Science and Technology,
science@consulfrance-boston.org
- Emmanuelle Deponge, Institut Curie
emmanuelle.deponge@curie.fr
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
In vivo information… …from in vitro tools
|
| Date: |
Monday October 16, 2006 |
| Description: |
WatchFrog creates and markets innovative solutions for the in vivo selection of a wide range of chemical, pharmaceutical and cosmetic substances.
On the one hand, culture-based in vitro screening risks eliminating interesting leads while in vivo screening is considered too slow and too expensive. WatchFrog incorporates in vivo significance with early in vitro stages, accelerating drug discovery.
The new generation of WatchFrog tests “light up”, providing biological answers using fluorescent-based screening in translucent amphibian models.
Amphibian development reproduces every key event of vertebrate organogenesis within an exceedingly short time frame (72h).
This is why, for years, scientists have used the tadpole for studying the cellular basis of cancer: apoptosis, immune response, proliferation.
Similarly the model can be used to assess neurotoxic effects of potential therapeutic agents.
Now, molecular signals associated with cell division and death can be followed on-line.
Our new generation small model organisms allows these processes to be studied in a tissue specific manner using semi-robotized screening.
For more information and online registration: www.bioteam.fr
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Equity Allocation and Your Venture: Noam Wasserman "Rich vs King"
|
| Date: |
Wednesday October 11, 2006 |
| Description: |
Many conversations among Harvard Alumni Startups members have focused on one decision that all founders face: how to slice the ownership pie. Now is your chance to gain new insights on the topic from your peers and from a special guest speaker.
On October 11th, Harvard Alumni Startups will host an evening with Noam Wasserman, (PhD 2002, MBA 1999). Noam, now an Assistant Professor at HBS, will talk about his paper, "Rich vs. King" -- and will share the highlights from his research on the relationship between startup success and equity allocation.
When: October 11th, 7-9pm
Where: 1730 Cambridge Street (CGIS South Building Room S020 on Harvard campus), Cambridge, MA
$20 payable at the door. Free with valid Harvard student ID.
This event is made possible by the generous sponsorship of Glance Networks (www.glance.net).
Please register for this event via the following form available at:
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
GSAS Harvard Biotechnology Club 7th Annual Business Plan Competition
|
| Date: |
Monday May 15, 2006 |
| Description: |
The GSAS Harvard Biotechnology Club announces the seventh annual Biotechnology Business Plan Competition with sponsorship from Merck Research Laboratories (MRL)-Boston, Cummings Properties.
The GSAS Harvard Biotechnology Business Plan Competition is unique in that it focuses exclusively on biotechnology start-ups. The 2005 Biotechnology Business Plan competition is open to entrepreneurs, students and professionals worldwide, and does not require Harvard University affiliation. The competition offers a $5,000 cash award for the first prize. An additional prize of a one-year lease for 1000 sq ft of lab/office space ($25,000 value) has been generously donated by Cummings Properties and will be granted to the highest placing entry that can utilize the space. The competition presents the opportunity for early stage biotechnology companies to have their business plans reviewed by seasoned venture capitalists and other biotechnology experts in the Boston area.
Schedule Of Events
Leading up to the competition, the GSAS Harvard Biotechnology Club is hosting a series of panel discussions. These panels are designed to address just a few of the many issues faced by entrepreneurs trying to start a company. All seminars and panels are open to the public.
Wednesday, March 22nd, 4:00 - 6:00pm
Getting Your Biotech Start-Up Seed Funded
Speaker: Steve Wardell: Principle, Apeiron Partners LLC
Harvard Medical School, New Research Building, HIM Lecture Room 1
Thursday, April 25th, 4:00 - 6:00pm
Alternative Funding and Business Law Panels
Harvard Medical School New Research Building, Rotunda
Monday, May 1st, 4:00 - 6:00pm
Venture Capital and Intellectual Property Panels
Harvard Medical School, New Research Building, Rotunda
Monday, May 15th, 5:00pm
Business Plan Competition Submission Deadline
Friday, June 2nd, 5:00pm
Finalist Presentations and Awards Ceremony
For more information about the Biotechnology Business Plan Competition, the Biotech Club, or becoming a sponsor, visit www.thebiotechclub.org/industry/startup/bplan.php or contact Patrick Loerch, patrick@thebiotechclub.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Consulting Career Panel
|
| Date: |
Wednesday May 10, 2006 |
| Description: |
The GSAS Harvard Biotechnology Club
Presents:
What: Consulting Career Panel
When: Wednesday, May 10th 2006, 4-6pm
Where: Harvard Medical School
260 Longwood Avenue
C-Building Cannon Room
Meet successful scientists & learn about their unique career paths. Explore the possibilities of consulting in the biotech/pharma industry as a career option for scientists. Please join us for an interactive & informative discussion. Light refreshments will be served.
Panelists:
• Chris Pashos, Ph.D.
Executive Director: Health Economics Research, Abt Associates
• Avi Kogan, Ph.D.
Consultant, The Monitor Group
• Antonio Pregueiro, Ph.D.
Senior Business Analyst, Trinity Partners
• Kimberly Howland, Ph.D.
Manager, Health Advances, LLC
• Geoff Whitehead, Ph.D.
Associate, PRTM
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Venture Capital and Intellectual Property Panels
|
| Date: |
Monday May 1, 2006 |
| Description: |
Leading up to the 7th Annual Business Plan Competition, the GSAS Harvard Biotechnology Club presents the Venture Capital and Intellectual Property Panels
What: Venture Capital and Intellectual Property Panels
When: Monday, May 1st, 4:00 - 6:00pm
Where: Harvard Medical School, New Research Building, Rotunda
Boston, MA
The venture capital panel discussion will feature VCs from the Boston area with a focus on the life science industry. Topics covered will include the current state of investment in the biosciences, recommendations on writing and marketing a strong business plan and criteria used by VCs to assess a new business idea. Panelists will field questions from the audience, with a focus on issues pertinent to scientists aspiring to launch business ventures in the life sciences
The IP panel will feature experienced attorneys and technology transfer specialists discussing how to navigate the licensing and patent hurdles involved in bringing a technology to the marketplace. The format will be highly interactive, with audience participation encouraged.
Intellectual Property Panelists:
Thomas Saunders, J.D.
Patent Law Attorney, Brown Rudnick Berlack Israels
O. Prem Das, Ph.D.
Office of Technology Licensing & Industry Sponsored Research, HMS
Andrea Schievella, Ph.D.
Technology Transfer Officer/Business Development & Licensing, MIT
Jeffrey L. Quillen, J.D.
Patent Law Attorney, Foley Hoag LLC
Venture Capital Panelists:
Jeffrey Moore
Associate, Research Corporation Technologies
Amir Nashat
Principle, Polaris Ventures
Zach Jonasson
Senior Principle, Seaflower Ventures
For more information on the Business Plan Competition or the venture capital and intellectual property panels contact Kanchan Mirchandani or visit http://www.thebiotechclub.org/industry/startup/bplan.php |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Alternative Funding and Business Law Panels
|
| Date: |
Tuesday April 25, 2006 |
| Description: |
Leading up to the 7th Annual Business Plan Competition, the GSAS Harvard Biotechnology Club presents the Alternative Funding and Business Law Panels.
What: Alternative Funding and Business Law Panels
When: Thursday, April 25th, 4:00 - 6:00pm
Where: Harvard Medical School New Research Building, Rotunda
Boston, MA
Alternative Funding Panel: The alternative funding panel focuses on less publicized sources of funding options for entrepreneurs. With venture capitalists preferring to invest in later stage start-up and requiring a larger percentage of ownership entreprenuers are looking elsewhere for the funds they require to get their companies off the ground. Panelists will discuss funding options available to entrepreneurs apart from venture capitalists, including SIBR grants, loans and angel investing. The format will be informal and we encourage audience members to bring questions.
Business Law Panel: New companies often start up on nothing more than the merit of a good idea. Entrepreneurs don't give much thought to how to deal with professional vendors such as bankers, attorneys, accountants and so on. With a little thought and effort, entrepreneurs can ensure to get the most from your vendor/customer/employee by building good relationship with your attorney. Your attorney's primary goal is to protect your interests. Attorneys take that job seriously, and their training gives them a different perspective than that of many entrepreneurs. In this event, entrepreneurs, scientists, and attorneys will share their perspectives on topics including: Corporation and liability, Corporate Structure, Incorporation, Disclaimers and Founders stock.
Alternative Funcing Panelists:
Janice Bourque
Senior Vice President and Group Head-Life Sciences, Comerica Bank
Dana Ono, Ph.D.
Managing Director, Life Sciences, VIMAC Ventures LLC
Phil Weilerstein
Executive Director, National Collegiate Inventors & Investors Alliance (NCIIA)
John J. Schwartz, Ph.D.
Director - Life Sciences, Stage1 Strategies
Business Law Panelists:
Gabor Garai, J.D.
Partner, Foley & Lardner LLP
Lin J. Hymel, Ph.D., JD
Associate, Edwards Angell Palmer & Dodge LLP
Roque El-Hayek, MD, JD
Associate, Wolf, Greenfield & Sachs PC
For additional information about the Biotechnology Business Plan Competition, the Biotech Club visit www.thebiotechclub.org/industry/startup/bplan.php or contact Patrick Loerch, patrick@thebiotechclub.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Women in Biotechnology, Pharmaceutical and Biotech Research Panel
|
| Date: |
Monday April 17, 2006 |
| Description: |
Panelists:
Grace Wong, Ph.D.
Chief Scientific Officer, ActoKine Therapeutics
Vivian Berlin, Ph.D.
Principal at BIOLyNX LLC
The Women in Biotechnology series will be an excellent opportunity to meet with successful women who have taken different approaches to science and have all excelled. This panel will examine the possibilities of research in the pharmaceutical and biotechnology industry as a career for scientists. The three major themes for the panel discussion will be: How these successful women go to where they are now, how they overcame any extra challenges they faced in their career, and how did they deal with the issues surrounding the creation of a healthy balance between professional success and family development. Please join us for an interactive and educational discussion.
The event will take place in the Cannon Room, C building, Harvard Medical School Quad, 240 Longwood Ave, Boston, MA 02115
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Women in Biotechnology: Intellectual Property, Venture Capital, and Patent Law
|
| Date: |
Monday April 3, 2006 |
| Description: |
In this seminar series, we will feature several courageous women who were trained in biological sciences, and made many career transitions in finding and pursuing their passions, and in balancing and living their lives. They come from different backgrounds, travelled different paths, and balanced their life in different ways. But they have one thing in common. They all have dared to venture out of their comfort zone and begin living fulfilling lives.
The Panelists:
Debra A. Peattie, Ph.D.
Chief Technology Officer, Valeo Mecial Inc.
Leena H. Karttunen, Ph.D., J.D.
Patent Attorney, Nixon Peabody LLP
Beth E. Arnold, M.S., J.D.
Partner, Foley Hoag LLP
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Funding Innovation: Steve Wardell: Principle, Apeiron Partners
|
| Date: |
Wednesday March 22, 2006 |
| Description: |
Funding Innovation:
Who: Steven Wardell: Principle, Apeiron Partners
Where: Harvard Medical School, HIM Room 138
When: Wednesday March 22nd, 4-6pm
The life science industry has changed dramatically over the past 5 years, and the biotech venture capital industry even more so, leading to the creation of the “Capital Gap” in the funding of life science start-ups. What sort of start-ups are venture funds willing to fund today and what stage do they have to be at in order to attract funding? Which venture funds are still willing to invest in early-stage start-ups? Steve Wardell, a Principal at Apeiron Partners LLC, a boutique life science investment bank with a $100m venture fund, will address these questions and explain what his fund is currently investing in.
BIO:
Steven Wardell is a Principal at Apeiron Partners. He has worked on over 25 major life science engagements with Apeiron Partners and has over 7 years of business development, corporate finance, and financial analysis experience. Prior to Apeiron Partners, he worked in M&A at Salomon Smith Barney on Wall Street. Mr. Wardell assists Apeiron Partners clients in business development and corporate finance transactions and frequently fills an operating role at a newco as part of an engagement. Before Apeiron Partners, Mr. Wardell worked on Wall Street where he participated in over $20 billion worth of M&A and financing transactions at Citigroup (Salomon Smith Barney) in healthcare, technology, and other sectors. Steve is the Director for Dinner Series of the Harvard Business School Health Industry Alumni Association." He holds an MBA from Harvard Business School, an MPhil from Cambridge University, and a BA from Harvard College. NASD registered broker-dealer, Series 7, 24 & 63.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Intrapreneurial & Entrepreneurial Women in Life Sciences --blazing their own trails
|
| Date: |
Monday March 20, 2006 |
| Description: |
What: Intrapreneurial & Entrepreneurial Women in Life Sciences --blazing their own trails
When: Monday March 20th, 4:30pm-6:00pm
Where: Cannon Room, C Building
Harvard Medical School Quad
240 Longwood Ave, Boston
In this seminar series, we will feature several courageous women who were trained in biological sciences, and made many career transitions in finding and pursuing their passions, and in balancing and living their lives. They come from different culture background, went through different paths, and balanced their life in different ways. But they have one thing in common. They all have dared to venture out of their comfort zone and begin living fulfilling lives.
Jiahong Juda, PhD, Co-Founder of WEST: Moderator
Dr. Jiahong Juda is the co-founder, and recent President and CEO of Women Entrepreneurs in Science and Technology (WEST). Trained as a physicist, she has always had a passion for applied science. About five years ago, she made the transition from the academic environment to a startup company, where she discovered her entrepreneurial aspiration. After searching extensively, she did not find a suitable environment for "business clueless" scientists or engineers to learn and develop intra/entrepreneurial skills until she and two colleagues co-founded WEST in 2000. Jiahong has recently retired as president of WEST, is currently working as a consultant and developing a course entitled ‘Personal Strategic Growth’ which was recently showcased at MIT.
Vivian Berlin, PhD, Principle BIOLyNX LLC
Vivian Berlin has 15 years of experience in the biotechnology industry holding positions in research management and business development at Vertex Pharmaceuticals, Mitotix and GPC Biotech. She led multiple research efforts moving programs from concept to late preclinical development. Dr. Berlin established proprietary positions in a number of therapeutic areas and has 13 issued patents. She is currently a Principal at BIOLyNX LLC providing research and corporate development strategy services to companies in the life sciences. She is also engaged in founding a company focused on the development of a diagnostic for ovarian cancer. Dr. Berlin received her M.S. at the Harvard School of Public Health, Ph.D. in Biology at Stanford University and postdoctoral training at the Whitehead Institute at MIT.
Lydia Villa-Komaroff, PhD, CSO Cytonome, Inc
Lydia Villa-Komaroff began her research career under the tutelage of David Baltimore and Harvey Lodish at MIT, and received a Ph.D. in Cell Biology in 1975. Her varied and active professional life includes research positions at Harvard University, the University of Massachusetts Medical Center, Cold Spring Harbor, and Children's Hospital in Boston. From 1998 to 2003 she was Vice President for Research at Northwestern University in Illinois and from 2003 to 2005 she served as Vice President for Research and Chief Operating Officer of the Whitehead Institute in Cambridge. She is currently Chief Scientific Officer of Cytonome.
She is a member of the Hispanic Engineer National Achievement Hall of Fame and a fellow of the Association for Women in Science. She has served on review committees for the National Institutes of Health and National Science Foundation. She was a member of the Institute of Medicine Committee on Assessing the System for Protecting Human Research Subjects, the National Research Council Committee on the Structure of NIH, the congressionally mandated National Science Foundation Committee on Equal Opportunity in Science and Engineering, as well as the National Science Foundation Advisory Committee for the Biology Directorate, which she chaired from 1997 to 1998. She was a member of the National Advisory Neurological Disorders and Stroke Council from 2000 to 2004 and was elected to the Board of Directors of the American Association for the Advancement of Science in 2001. She is a founding member of the Society for the Advancement of Chicanos and Native Americans in Science and has been both a board member and vice president of the organization. She was appointed to the Board of Directors of Transkaryotic Therapies, Inc (TKT) in 2003, a biopharmaceutical company that developed products for the treatment of rare diseases. She became Chair of the Board in January 2005 and guided the deliberations and process that led to the sale of TKT for $1.6B.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
7th Annual GSAS Harvard Biotechnology Club Business Plan Competition
|
| Date: |
Monday March 13, 2006 |
| Description: |
The GSAS Harvard Biotechnology Club Announces:
The 7th Annual Biotechnology Business Plan Competition
The GSAS Harvard Biotechnology Club announces the seventh annual Biotechnology Business Plan Competition with sponsorship from Merck Research Laboratories (MRL)-Boston, Cummings Properties.
The GSAS Harvard Biotechnology Business Plan Competition is unique in that it focuses exclusively on biotechnology start-ups. The 2005 Biotechnology Business Plan competition is open to entrepreneurs, students and professionals worldwide, and does not require Harvard University affiliation. The competition offers a $5,000 cash award for the first prize, and a $1,000 cash award for second prize. An additional prize of a one-year lease for 1000 sq ft of lab/office space ($25,000 value) has been generously donated by Cummings Properties and will be granted to the highest placing entry that can utilize the space. The competition presents the opportunity for early stage biotechnology companies to have their business plans reviewed by seasoned venture capitalists and other biotechnology experts in the Boston area.
Schedule Of Events
Leading up to the competition, the GSAS Harvard Biotechnology Club is hosting a series of panel discussions. These panels are designed to address just a few of the many issues faced by entrepreneurs trying to start a company. All seminars and panels are open to the public.
Wednesday, March 22nd, 4:00 - 6:00pm
Getting Your Biotech Start-Up Seed Funded
Speaker: Steve Wardell: Principle, Apeiron Partners LLC
Harvard Medical School, New Research Building, HIM Lecture Room 1
Thursday, April 25th, 4:00 - 6:00pm
Alternative Funding and Business Law Panels
Harvard Medical School New Research Building, Rotunda
Monday, May 1st, 4:00 - 6:00pm
Venture Capital and Intellectual Property Panels
Harvard Medical School, New Research Building, Rotunda
Monday, May 15th, 5:00pm
Business Plan Competition Submission Deadline
Finalist Presentations and Awards Ceremony
Date & Location: To Be Announced
For more information about the Biotechnology Business Plan Competition, the Biotech Club, or becoming a sponsor, visit www.thebiotechclub.org/industry/startup/bplan.php or contact Patrick Loerch, patrick@thebiotechclub.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Networking 101
|
| Date: |
Friday January 27, 2006 |
| Description: |
What: Networking 101
Who: Michele Ayan: President & Founder of 180 Global Marketing
When: January 27, 2006: 4-6pm
Where: Harvard Medical School Quadrangle, Cannon Room
Networking, it’s one of those topics you hear about no matter what field you’re in, even medicine and science. Most people acknowledge that networking plays a key role in building a successful career in both industry and academia.
However, just what networking is and how it can be accomplished remains a mystery for many people, especially in an industry setting. As a result, most of us do not give networking much thought until suddenly we find ourselves searching for our next (or first) career move, sitting at home with our rolodex (if we have one) and wondering “Who do I call now?”
Michele Ayan, of 180 Global Marketing, will give an interactive seminar on the “Do’s and Don’ts” of networking. Topics will include: how to get started, building and maintaining your network, as well as some advanced networking techniques.
Michele Ayan is the President and Founder of 180 Global Marketing, a marketing firm dedicated to driving the success of its clients. Ms. Ayan has over 10 years of Professional Marketing experience. Before launching her consulting practice, Michele served as the Director of Marketing of Testa, Hurwitz & Thibeault, LLP, a leading global law firm that serves emerging growth companies and the venture capital and private equity communities that finance them.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
GSAS Harvard Biotechnology Club Career Fair
|
| Date: |
Thursday October 6, 2005 |
| Description: |
GSAS Harvard Biotechnology Club Career Fair
Thursday, October 6th, 2005, 1-5 PM
Harvard Medical School
Boston, MA
Have (or soon will have) a PhD and are looking for a non-academic career? Need talented PhDs with biological/medical research experience for your company? Please join us on October 6, 2005 from 1-5 PM for the GSAS Harvard Biotechnology Club Career Fair at Harvard Medical School.
This year’s fair is sponsored by Science Careers and will include representatives from a mix of biotech, pharmaceutical, patent law and consulting companies looking to hire PhDs. A variety of non-academic career options, from bench science to business applications, will be presented through company booths, presentations and panel discussions. In previous years an estimated 1000 Harvard-affiliated job seekers, including graduate students, postdocs, fellows, and medical students have attended and as many as 34 companies have participated in this event.
Career Fair Schedule
Tuesday, October 4th
Panel: Career Opportunities in Industry: Merck-Boston
Merck Scientists discuss and contrast research in industry and academia. They talk about the career opportunities at Merck-Boston, what they look for in scientists and give insight into the decision on whether to make the transition from academia to industry.
Time : 4:00 to 5:30 PM
Venue : C-Building, Cannon Room
Harvard Medical School Quadrangle
Longwood Medical Area (map)
Boston, MA 0211
Wednesday, October 5th
Panel: Alternative Careers in Science
The GSAS Harvard Biotechnology Club presents a panel discussion addressing non-traditional career paths for scientists. Panelists with Ph.Ds in the life-sciences who have excelled in areas encompassing Business Development, Biotechnology Consulting, Venture Capital and Patent Law will shed light on exciting choices currently available to scientists seeking to make meaningful contributions outside the realm of traditional scientific research.
Time : 5:00 to 6:00 PM
Venue : New Research Building
3rd Floor Rotunda
Harvard Medical School
Longwood Medical Area (map)
Boston, MA 02115
Thursday, October 6th
Annual Career Fair
Time : 1:00 to 5:00 PM
Venue : New Research Building
3rd Floor Rotunda
Harvard Medical School
Longwood Medical Area(map)
Boston, MA 02115
1-5PM Company Tables
1-4PM Company Presentations
Companies that are interested in participating should register by September 6, 2005, using the company registration form at http://www.thebiotechclub.org.
More information can be found at our website http://www.thebiotechclub.org. Further questions can be addressed to Patrick Loerch at patrick@thebiotechclub.org.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Harvard Biotechnology Club Announces the Winners of the 2005 Biotechnology Business Plan Competition
|
| Date: |
Friday June 17, 2005 |
| Description: |
Boston, June 10 2005 -- In the 2005 Biotechnology Business Plan Competition organized by the GSAS Harvard Biotechnology Club, Claros and Vascular Precision were awarded the top prizes by a panel of judges composed of leading venture capital firms.
At the award ceremony was hosted by Brown Rudnick Berlack Israels LLP Claros was awarded the first prize in the competition. The judges clearly favored Claros in the competition stating that they possess the combination of a solid team and a clear solution to complex problem with a large market. Claros has designed an easy-to-use device that performs complex immunoassays with minimal time and resources. The company has chosen the STD market to launch the device where it is primed for rapid adoption in the home market due to privacy issues with STD testing. Thekla Diehl, the director of the competition said that with their management team and novel device it was clearly a winner for this competition. Claros walked away with a legal package from Brown Rudnick, $25,000 credit towards leasing lab space with Cummings Properties and a $5000 cash prize.
The second place prize was awarded to Vascular Precision who have developed a novel vascular closure device for large arteriotomy sites that meets a well-defined market with unmet needs. Vascular Precision's products enable surgeons to close both large and small
arteriotomies percutaneously and achieve complete hemostasis along the
entire arteriotomy profile, regardless of its size. Vascular Precision was also awarded a legal package from Brown Rudnick as well as a $1000 cash prize.
Judges in the competition included representatives from the following venture firms: Flagship Ventures, Oxford Bioscience Partners, CPP Capital, Versant Ventures, Seaflower Ventures, Venrock and PureTech Ventures. The prizes and competition were made possible through the continued support of Brown Rudnick Berlack Israels LLP, Cummings Properties and Merck Research Laboratories-Boston.
The GSAS Harvard Technology Club is a non-profit organization with over 5,000 members in both industry and academia. Among other activities, the club hosts events and provides services that allow members to explore the worlds of business and biotechnology. The Club’s mission is to bridge the gap between industry and academia by building relationships with companies operating in the biotechnology and healthcare sphere. Corporate sponsorship support all club activities and operations.
To learn out more about the 2005 Biotechnology Business Plan Competition or the GSAS Harvard Biotechnology Club please contact Patrick Loerch, Managing Director (617) 938-6228 – patrick@thebiotechclub.org or visit www.thebiotechclub.org.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
The GSAS Harvard Biotechnology Club Announces the 6th Annual Biotechnology Business Plan Competition
|
| Date: |
Sunday May 15, 2005 |
| Description: |
The GSAS Harvard Biotechnology Club
Announces the Sixth Annual Biotechnology Business Plan Competition
Brown Rudnick and Merck Research Laboratories Sponsor Competition
to Foster Emerging Technology Companies
The GSAS Harvard Biotechnology Club announces the sixth annual Biotechnology Business Plan Competition with sponsorship from the international law firm of Brown Rudnick Berlack Israels LLP, Merck Research Laboratories (MRL) and the Technology & Entrepreneurship Center at Harvard (TECH).
The GSAS Harvard Biotechnology Business Plan Competition is unique in that it focuses exclusively on biotechnology start-ups. The 2005 Biotechnology Business Plan competition is open to entrepreneurs, students and professionals worldwide, and does not require Harvard University affiliation. The competition offers a $5,000 cash award for the first prize, and a $1,000 cash award for second prize. It also presents the opportunity for early stage biotechnology companies to have their business plans reviewed by seasoned venture capitalists and other biotechnology experts in the Boston area.
Leading up to the competition, the GSAS Harvard Biotechnology Club is hosting a series of workshops designed to assist applicants. Workshops will teach the basics of writing a business plan and how to tackle some of the corporate, intellectual property and organizational hurdles faced by start-up companies in the biotech sector. This series will conclude with our annual Venture Capital and IP/Tech Transfer Q&A panels. All of the events are open to the public and will be held in the rotunda of the Harvard Medical School NRB building in Boston, MA.
For additional information about the Biotechnology Business Plan Competition, the Biotech Club, or becoming a sponsor, please contact Thekla Diehl, tdiehl@thebiotechclub.org or Patrick Loerch, patrick@thebiotechclub.org or visit www.thebiotechclub.org.
Schedule of Events:
Wednesday, April 13th, 4:00 – 6:00pm
Speakers: Dr. Joe Lassiter and Dr. Mike Roberts, Harvard Business School
4:00 - 4:50pm The Basics of Writing a Business Plan
5:10 - 6:00pm A Critique of 2004’s Competition Finalists, NeuroHealing Pharmaceuticals
and Mujisan Pharmaceuticals
Thursday, April 28th, 4:00 – 6:00pm
Speakers: Dr. Lee Fleming and Dr. Noam Wasserman, Harvard Business School
4:00 - 4:50pm Founders and Teams in a Start-up Company
5:10 – 6:00pm Cambridge vs Silicon Valley as Start-up Environments
Thursday, May 5th, 4:00 – 6:00pm
Venture Capital and IP/Tech Transfer Panels
Panelists: To Be Announced
Sunday, May 15th
Business Plan Competition Submission Deadline
Thursday, June 2nd, 7:00 – 9:00pm
Final Awards Ceremony and Reception
|
| File Attachments: |
File (None)
JPEG(None)
PDF()
|
|
Annual Venture Capital and IP/Technology Transfer Panel Discussions
|
| Date: |
Thursday May 5, 2005 |
| Description: |
THE 6th ANNUAL GSAS HARVARD BIOTECHNOLOGY CLUB BUSINESS PLAN COMPETTION VENTURE CAPITAL AND IP/TECH TRANSFER PANELS
May 5th 2005
Harvard Medical School NRB 3RD Floor Rotunda
Sponsered by Brown Rudnick Berlack Israels LLP
and Merck Research Laboratories-Boston
A moderated discussion of what venture capitalists look for in a start-up company, accompanied by a look at some of their most recent funding decisions. This will be followed by an overview of how to navigate the licensing and patent hurdles involved in bringing a technology into the marketplace and how much IP is enough.
Venture Capitol Panel:
· Doug Cole, Flagship Ventures
· Kolol Pal, Pure Tech Ventures
· Monica Vnuk, Oxford Bioscience Partners
· David Stone, Flagship Ventures
IP/Tech Transfer Panel:
· Brenda Maning, Vice President, Children’s Hospital Tech Transfer Office
· Kenneth Levin, Senior Technology Manager, Harvard Medical School Tech Transfer Office
· Chester Bisbee, Director, University of Massachusetts Medical School Tech Transfer Office
· Thomas Saunders, Partner, Brown Rudnick Berlack Israels LLP
When: Thursday, May 5th, 2005 4:00 PM
Where: Harvard Medical School
New Research Building 3rd Floor Rotunda
77 Avenue Louis Pasteur
Boston, MA 02115
|
| File Attachments: |
File (531_VC_IP_Panel_Flyer.doc)
JPEG(None)
PDF(None)
|
|
A PRACTICAL WORKSHOP ON THE BASICS OF WRITING A BUSINESS PLAN
|
| Date: |
Wednesday April 13, 2005 |
| Description: |
A PRACTICAL WORKSHOP ON THE BASICS OF WRITING A BUSINESS PLAN
To kick-off the Sixth Annual Biotechnology Business Plan Competition the GSAS Harvard Biotechnology Club would like to announce the first of its business plan workshops.
On April 13th at the Harvard Medical School NRB Building Professors Joe Lassiter and Mike Roberts from the Harvard Business School will lead a workshop on the basics of writing a business plan. They will describe the basic anatomy of a business plan, as well as supply a practical guide on how to begin and where to find the information you’ll need to compose a viable plan. Following a brief coffee break, the second half of the workshop will consist of a detailed critique of 2004’s Competition Finalists, NeuroHealing Pharmaceuticals and Mujisan Pharmaceuticals, whose business plan summaries are supplied below. For more information on this year’s Biotechnology Business Plan Competition please contact Thekla Diehl at tdiehl@thebiotechclub.org or visit our website at http://www.thebiotechclub.org/industry/startup/bplan.php.
DATE: Wednesday, April 13th, 4:00 – 6:00pm
SPEAKERS: Dr. Joe Lassiter and Dr. Mike Roberts, Harvard Business School
LOCATION: Harvard Medical School, NRB Building
77 Avenue Louis Pasteur
Boston, MA 02115
http://www.theconfcenter.hms.harvard.edu/directions/
SCHEDULE: 4:00 - 4:50pm The Basics of Writing a Business Plan
4:50 – 5:10pm Coffee Break
5:10 - 6:00pm A Critique of 2004’s Competition Finalists, NeuroHealing Pharmaceuticals and Mujisan Pharmaceuticals
Neurohealing Pharmaceuticals Summary
Product/Service: Drug Discovery and Development
Website: http://www.nhpharma.com/
NeuroHealing Pharmaceuticals provides therapies to improve the post-acute neuro-rehabilitation process and functional outcome for patients who have suffered debilitating injuries to the central nervous system. NeuroHealing has recently demonstrated promising results with its first product, NH001, in minimally conscious and vegetative state patients. Targeting a US market potential of over $1 billion. Guided by a strong management team, NeuroHealing plans to become the leading pharmaceutical company addressing the needs of the under-served neuro-rehabilitation patients, who currently face rehab costs exceeding $35 billion annually. Major chronic neuro-rehabilitation patients include victims of traumatic brain injury, stroke, spinal cord injury, multiple sclerosis and degenerative diseases such as Parkinson’s and Alzheimer’s
Mujisan Pharmaceuticals Summary
Product/Service: Drug Delivery
Contact: David Wang
Mujisan Pharmaceuticals is a start-up drug delivery company based on our proprietary drug polymer technology, PolyRx. It represents a novel sustained-release (SR) formulation strategy that forms polymers using individual drug molecules as the building blocks. The key advantages of this technology are two-fold: (1) The SR mechanism is tamper-proof as the active drug is released only physiologically and, unlike competing platforms, cannot be mechanically compromised; (2) more drug can be loaded in each pill, allowing for SR for 24 hours and thus improved analgesic efficacy.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Intrapreneurs: Women in Biotech: Mara Aspinall, Pres. Genzyme Genetics
|
| Date: |
Wednesday March 30, 2005 |
| Description: |
Intrapreneurs: Women in Biotechnology
Mara Aspinall, President, Genzyme Genetics
GSAS Harvard Biotechnology Club continues to bridge the gap between academia and industry by presenting the second installment of “Intrapreneurs: Women in Biotechnology” on Wednesday, March 30, 2005.
This year, our women in biotechnology event will be a series featuring successful women who have made their mark as either entrepreneurs or intrapreneurs. Intrapreneurs are individuals who innovate and create change within a larger organization. This second lecture in our series will feature Mara Aspinall, MBA, President of Genzyme Genetics. Genzyme Genetics is a world leader in diagnostic testing services, with particular interest in prenatal care and cancer. Aspinall joined Genzyme in 1997 as vice president of corporate development. Prior to joining Genzyme, Aprinall was a director at the law firm Hale and Dorr LLP, and a senior consultant with Bain & Company. She holds an MBA from Harvard Business School and an undergraduate degree from Tufts University. Please join us to hear her inspiring story! As always, men are encouraged to attend.
Who: Mara Aspinall, MBA
What: Intrapreneurs: Women in Biotechnology
When: Wednesday, March 30th, 2005, 4:00 PM
Where: Harvard Medical School/HIM Lecture Room
77 Avenue Louis Pasteur
Boston, MA 02115
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Intrapreneurs: Women In Biotech: Weng Tao, CSO and VP R&D, Neurotech
|
| Date: |
Wednesday March 23, 2005 |
| Description: |
Intrapreneurs: Women in Biotechnology
Weng Tao, CSO and VP R&D, Neurotech
GSAS Harvard Biotechnology Club continues to bridge the gap between academia and industry by presenting the kickoff installment of “Intrapreneurs: Women in Biotechnology” lecture series on Wednesday, March 23, 2005.
This year, our women in biotechnology event will be a series featuring successful women who have made their mark as either entrepreneurs or intrapreneurs. Intrapreneurs are individuals who innovate and create change within a larger organization. This event will feature Weng Tao, M.D., Ph.D., Chief Scientific Officer and Vice President of Research and Development at NeuroTech. At NeuroTech, Weng Tao oversaw the development of Encapsulated Cell Technology (ECT) products, which allow effective drug delivery to the retina, with the ultimate goal of treating retinal diseases. Phase I human trials are currently underway for this technology. Trained as a pediatrician
in China, Dr. Tao came to the US, earned a PhD in cell biology and biophysics, and completed post-doctoral studies in molecular biology. After her first company failed to capitalize on promising technology, Dr. Tao forged an alliance with another company, and was able to create NeuroTech.
Jiahong Juda of WEST will introduce our speaker and discuss the qualities of a successful intrapreneur. Please join us to hear her inspiring story! As always, men are encouraged to attend.
Who: Weng Tao, M.D., Ph.D.
Introduction to be given by Jiahong Juda, President and CEO, WEST
What: Intrapreneurs: Women in Biotechnology
When: Wednesday, March 23rd, 2005, 4:00 PM
Where: Harvard Medical School/ NRB Rotunda
77 Avenue Louis Pasteur
Boston, MA 02115
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
4th Annual North America Forum for Investing and Partnering in Biotech and Medtech
|
| Date: |
Wednesday March 16, 2005 |
| Description: |
4th Annual North America Forum for Investing and Partnering in Biotech and Medtech
Hosted by Sachs Associates and in conjunction with Bloomberg LLP
16 – 17 March 2005, The Fairmont Copley Plaza, Boston
Exclusive Legal Sponsor: Palmer & Dodge
Co Sponsors: The American Stock Exchange, Boehringer Ingelheim, Invest Australia, SWX Swiss Exchange
Opportunities to attend or present - now strictly limited!
The North America Forum has already attracted delegates from some of the leading biotechs, big pharmas and fund managers including Eli Lilly & Company, Genzyme Corp, Oxford Bioscience Partners, Atlas Venture and Flagship Ventures. Over 60 biotech and medtech companies are already confirmed to present to this specialist audience, which brings with it promises of extensive investment and partnership opportunities. The Forum also provides opportunity to gain strategic and tactical insight into how to implement strategic partnerships, successful acquisitions and crucial funding. Confirmed presenting companies include: Adherex Technologies Inc, YM BioSciences, Norwood Abbey Ltd, Aderis Pharmaceuticals, Atugen AG and Life Medical Sciences Inc. Please visit our website http://www.sachsforum.com/boston05_fs.html for a list of all confirmed presenting companies and attendees.
Our presenting package will give you the opportunity to give a 15 minute stand-alone presentation, to receive event branding, to meet with delegates and speakers in private meeting facilities (organized via an online system), to get access to all social events including lunches and cocktail receptions, receive complimentary delegate passes and much more.
Don’t miss out on your chance to take part in discussions with leading investors, biotechs and pharmas from throughout the US, Europe and beyond. Hear new insights concerning coming changes and discover how companies are already shifting strategies to take advantage of new opportunities and avoid future market threats. Learn where top leaders from the financial community anticipate growth – and where they see problems.
Whether you are interested in attending the event or presenting at the event in one of our sector workshops, please visit our website http://www.sachsforum.com/boston05_fs.html for further information or email Hannah-Louise Cook at hl@sachsforum.com if you wish to apply for a presentation.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Biomaterials and Tissue Engineering Course
|
| Date: |
Friday February 4, 2005 |
| Description: |
Spring 2005 Course: Biomaterials and Tissue Engineering in Medical Devices and Artificial Organs (HST-521)
Course Director: Frederick J. Schoen, MD, PhD (fschoen@partners.org)
Associate Course Directors: Jonathan J. Rosen, PhD; Gordana Vunjak-Novakovic, PhD
„« Focus on the structure, properties, and applications of biomaterials (synthetic or modified natural materials used to evaluate, replace tissues, organs or biological functions) and tissue engineering (use of biomaterials with incorporated cells and biological signals to stimulate tissue regeneration).
„« Provide an integrated biological/engineering academic/corporate approach.
„« Probe mechanisms and methods of evaluation for tissue/biomaterials and patient/device interactions.
„« Assess current challenges and cutting-edge technological solutions to medical problems.
Additional topics will include: key pathophysiological concepts of biomaterials-tissue and environment-tissue interactions; stem cells; biofunctional materials; nano-biomaterials; issues in design, development, fabrication and clinical evaluation; regulatory concerns; and novel research directions and applications of materials to medicine.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
GSAS Harvard Biotechnology Club: New Member Meeting
|
| Date: |
Thursday December 2, 2004 |
| Description: |
GSAS Harvard Biotechnology Club New Member Meeting
Thursday, December 2nd, 2004, 4:30 PM
Harvard Medical School
Room: Armenise Amphitheater
240 Longwood Ave, Boston, MA
The GSAS Harvard Biotechnology Club aims to expose its members to diverse professions that have risen around scientific research. Whether you are a student, post-doc, professor or budding entrepreneur, our goal is to introduce you to career opportunities outside of academia. There is no better way to learn about these opportunities than to help organize one of our events and work face-to-face with leaders in various biotech-related sectors.
Please join us at our new members meeting and learn how to become more involved. Food and refreshments will be provided. No academic affiliation is required for membership.
Some of Our Annual Events:
· Women in Biotech: Intrapreneur and Entrepreneur Panels
· Biotechnology Business Plan Competition
· Company Spotlight and Harvard Alumni Series
· Intellectual Property and Venture Capital Panels
· Biotech/Pharma Panel Discussions
· Patent Law Preview Panel
· Annual Career Fair
Please RSVP
Patrick Loerch, Managing Director
patrick@thebiotechclub.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
The GSAS Harvard Biotechnology Club Announces the Fifth Annual Biotechnology Business Plan Competiti
|
| Date: |
Saturday May 15, 2004 |
| Description: |
The GSAS Harvard Biotechnology Club Announces the Fifth Annual Biotechnology Business Plan Competition
International Law Firm Brown Rudnick Berlack Israels and Merck Research Laboratories Sponsor Competition to Foster Early-stage Company Growth
Boston, MA – March 15, 2004 -- The GSAS Harvard Biotechnology Club today announced the fifth annual Biotechnology Business Plan Competition with sponsorship from Brown Rudnick Berlack Israels LLP and Merck Research Laboratories (MRL).
The 2004 Biotechnology Business Plan competition is open to entrepreneurs, students and professionals worldwide, and does not require Harvard University affiliation. The competition offers a $5,000 cash award for the first prize, a $1,000 cash award for second prize and an opportunity for early stage biotechnology companies to have their business plans reviewed by seasoned venture capitalists focused on this industry and other biotechnology experts in the Boston area.
To enter, a team must submit in Adobe Acrobat™ format (1) their individual contact information, (2) a one paragraph summary of the company, (3) a two-page executive summary and (4) a business plan. These documents must be e-mailed to startup@thebiotechclub.org no later than Saturday, May 15, 2004. Submissions will be considered from early stage companies who have garnered less than $1 million in seed funding.
The GSAS Harvard Biotechnology Club will kick-off the business plan competition with a Venture Capital and IP/Licensing Panel event to be held at Harvard Medical School on April 28th. The event will provide helpful hints and insider wisdom on how to write a successful business plan and issues related to technology transfer and licensing. Brown Rudnick and the Biotech Club will host an awards ceremony for participants, judges and sponsors at the conclusion of the competition in June. Details for each event will be posted on the club’s Web site at www.thebiotechclub.org.
The organizers and judges respect the sensitive nature of the business plans and, as such, the Biotech Club will limit distribution of full business plans to participating judges only. The Biotech Club encourages teams to submit detailed plans, which will be reviewed and judged by senior venture capitalists and biotechnology industry experts affiliated with the competition. After the submission deadline, the Biotech Club will post on its Web site the one-paragraph summary of each competing company along with the company’s contact information. The GSAS Harvard Biotechnology Business Plan Competition is unique in that it focuses exclusively on biotechnology start-ups. In 2004, with the continued generous sponsorships of Brown Rudnick and Merck Research Laboratories, the Biotech Club hopes to achieve the tremendous success of previous competitions. The 2003 winners of the GSAS Harvard Biotechnology Club Business Plan Competition were Acceptys, Inc. and Hepatometrix. Summaries of some previously submitted plans may be viewed on the Biotech Club’s Web site.
For additional information about the Biotechnology Business Plan Competition, the Biotech Club, or becoming a sponsor, please contact Patrick Loerch, patrick@thebiotechclub.org or Mike Owens, mike@thebiotechclub.org or visit www.thebiotechclub.org. |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
The GSAS Harvard Biotechnology Club Announces the 2004 Venture Capital and IP/Tech Transfer Panels
|
| Date: |
Wednesday April 28, 2004 |
| Description: |
As a kick-off to the 2004 Biotechnology Business Plan Competition the GSAS Harvard Biotechnology Club announces the Fifth Annual Venture Capital and IP/Tech Transfer panels with sponsorship from Brown Rudnick Berlack Israels LLP and Merck Research Laboratories (MRL).
The 2004 Venture Capital and IP/Tech Transfer panels will be held on Wednesday, April 28th at 4:00pm in the rotunda of the Harvard Medical School NRB building. The panels are open to entrepreneurs, students, university staff and professionals, and do not require Harvard University affiliation.
In the VC panel, seasoned venture capitalists will provide insider wisdom on how to write a successful business plan and the common mistakes made by first-time entrepreneurs. The IP panel will supply insight into how to navigate the IP/licensing issues faced when starting a company based on academic research. It will also discuss the role of the university tech transfer offices in bringing university technologies into the marketplace and the rights and responsibilities of academic researchers.
Venture Capital Panel:
- Noubar Afeyan Ph.D., Senior Managing Director, Flagship Ventures
- Rob Mashal, M.D., Boston Millenia Partners
- Michael Lytton, Oxford Bioscience Partners
- Todd Foley, MPM Capitol
IP/Tech Transfer Panel:
- Joyce Brinton, Director, Harvard University Technology Transfer Office
- Kenneth Levin, Senior Technology Manager, HMS Technology Transfer Office
- Thomas Saunders, Partner, Brown Rudnick Berlack Israels LLP
- To Be Announced, MIT Technology Transfer Office
The 2004 Biotechnology Business Plan competition is open to entrepreneurs, students and professionals worldwide, and does not require Harvard University affiliation. The competition offers an opportunity for early stage biotechnology companies to have their business plans reviewed by seasoned venture capitalists focused on this industry and other biotechnology experts in the Boston area. In 2004, with the continued generous sponsorships of Brown Rudnick and Merck Research Laboratories, the Biotech Club hopes to achieve the tremendous success of previous competitions.
For additional information about the panel discussions, Biotechnology Business Plan Competition, the Biotech Club, or becoming a sponsor, please contact Patrick Loerch, patrick@thebiotechclub.org or Mike Owens, mike@thebiotechclub.org or visit www.thebiotechclub.org.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Women in Biotechnology Panel Discussion
|
| Date: |
Thursday April 15, 2004 |
| Description: |
GSAS Harvard Biotechnology Club, sponsored by Testa, Hurwitz, & Thibeault, LLP, continues to bridge the gap between academia and industry by presenting the third annual “Women in Biotechnology” roundtable to Harvard Medical School on Thursday, April 15th, 2004.
This series, first launched in 2002, is designed for female graduate students and post-doctoral fellows considering careers in the biotechnology industry. Since real-world experiences are the best possible tools for learning, the panel will address issues faced by women everyday in industry and business. Panelists featured in this event are among the leading ranked women in various areas of the biotechnology industry.
Who: Heidi R. Wyle, PhD, MBA, Founder and Chairman, Ardais Corporation
Barbara Fox, PhD, Founder, CSO, and President, Recovery Pharmaceuticals, Inc.
Monica Vnuk, MD, Associate at Oxford Biosciences IV
Judith Gwathmey, PhD, VMD, Founder, CEO, President, CSO, Gwathmey, Inc.
Elaine Caughey, MBA, Senior associate at Advanced Technology ventures
Moderator: Monica Higgins, PhD, MBA, Associate Professor, HBS
What: Third Annual Women in Biotechnology Panel Discussion
When: Thursday, April 15th, 2004
4:00 PM Refreshments
4:30 PM Panel Discussion
Where: Harvard Medical School/ NRB Amphitheater
77 Avenue Louis Pasteur
Boston, MA 02115
The panel disccusion is part of the club’s Spring 2004 Events Calendar, and is open to all registered members of the GSAS Harvard Biotechnology Club. Membership is free, as is attendance of all of its events. More information on membership is available at www.thebiotechclub.org.
Please RSVP to kontop@fas.harvard.edu
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Fall 2003 GSAS Biotechnology Club Alumni Seminar Series
|
| Date: |
Thursday November 6, 2003 |
| Description: |
Fall 2003 GSAS Biotechnology Club Alumni Seminar Series
Journey From Academic Researcher to Patent Attorney: The First Five Years
Dr. Michael Belliveau (Ph.D., Neurobiology, '98)
Harvard Division of Medical Sciences Alumnus
Patent Agent Clark & Elbing LLP
When: November 6th 4:00pm
Where: Harvard Medical School
Cannon Room, Bldg C.
Dr. Michael Belliveau (Ph.D., Neurobiology, '98) will be speaking on November 6, at 4:00 pm in the Cannon Room. Dr. Belliveau is currently a Patent Agent at Clark & Elbing, LLP, a Boston intellectual property law firm focused primarily on biotechology and pharmaceuticals. As a participant in Clark & Elbing's Technology Specialist program, Dr. Belliveau is also in his fourth year in the Evening Division of Suffolk University Law School.
Dr. Belliveau will discuss his transition from academic research to patent law and his experiences at Clark & Elbing and Suffolk.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
4th Annual GSAS Biotech Club Career Fair--Sponsored by Science Careers
|
| Date: |
Wednesday October 22, 2003 |
| Description: |
The Career Fair webpage is up and running. http://www.thebiotechclub.org/careerfair/generalinformation.html
The 2003 GSAS Harvard Biotechnology Club Career Fair will take place in Harvard Medical School’s Medical Education Center on October 22 from 2-6 pm. We are fortunate to have Science Careers sponsoring the event again this year.
Our location at Harvard Medical School is great for targeting the large and interdisciplinary Longwood Medical area in Boston. We draw scientists from all major institutions nearby, including the Dana Farber Cancer Institute, Children's Hospital, Brigham and Women's and Harvard Medical School.
In previous years, as many as 34 companies have participated and an estimated 1000 Harvard affiliated job seekers (post docs, fellows, medical students, and graduate students) have attended this event. In connection with the fair we are sponsoring a resume/interview workshop to help groom our candidates for the job search. Our Fair targets Harvard graduate students and postdoctoral fellows in biological and medical research. We try to present a wide range of career choices for PhDs - from bench science to business applications. This year's fair will consist of a mix of biotech, pharmaceutical, patent law and consulting companies looking to hire PhDs with experience in medical and biological research.
If your company is interested in participating in this year's career fair or you have any questions, please contact Mike Owens mike@thebiotechclub.org.
For more information, please visit:
http://www.thebiotechclub.org/careerfair/generalinformation.html
Current companies:
Novartis Institutes for BioMedical Research
Massachusetts Biological Labs
Health Advances LLC
Wolf Greenfield
Foley Hoag LLP
NUCRYST Pharmaceuticals
Syntapharma
Decision Resources
Phylonix Pharmaceuticals, Inc.
Clark and Elbing LLP
MIT Lincoln Laboratories
Also attending:
NatureJobs
CenterWatch
Presentation by:
Novartis
Career Panel discussion led by Pearl Freier |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Career Panel Discussion: Moving your career forward in Biotech
|
| Date: |
Wednesday October 22, 2003 |
| Description: |
Career Panel Discussion:
Moving Your Career Forward in Biotech (3 pm)
Representatives from Novartis and law firm Brown Rudnick are confirmed speakers and will discuss growth opportunities in the industry and at their respective companies, their perspectives as employers on what makes an attractive candidate, and suggestions for transitioning from academia to industry. The discussion will be moderated by executive search consultant Pearl Freier, a managing director with Talent Capital Group.
Panelists:
Mark A. Tepper PhD, President Araios
Dr. Tepper has over 25 years of experience in biomedical research with most of the last 15 years spent leading small molecule and protein therapeutic discovery and development projects in large pharma and biotech. In January 2003, Dr.Tepper joined Thermogenic Imaging Inc. as Chief Scientific Officer. Prior to that he was President and CEO of Arradial. From 1995 -2002, Dr. Tepper served in a number of senior management roles at the Serono in Rockland most recently as Vice President, Research and Operations and Head of Lead Discovery. At Serono, Dr. Tepper was responsible for early lead discovery, biological evaluation for both small molecule and protein therapeutics, and overall operation of the Institute.
Anthony Messina, Vice President Human Development, Arqule
Anthony S. Messina joined Arqule in 1997 and has served as the Vice President of Human Development since June 1999. Prior to joining ArQule, Mr. Messina was Vice President for Camden Consulting and Human Resources Manager for Varian Associates. He received his B.B.A. in management from the University of Massachusetts.
Thomas Saunders, Partner, Brown Rudnick
Mr. Saunders specializes in representing emerging medical technology, biotechnology/genetic engineering and pharmaceutical concerns, particularly as to patent prosecution, patent strategy and IP licensing matters. His practice also includes interference practice, trademark and copyright matters. Mr. Saunders has a substantial background in biotechnology and chemical patent practice, facilitated by his graduate studies in physiology at Case Western Reserve University and Albany Medical College. He has also been in-house patent counsel in the pharmaceutical industry.
Novartis Institutes for BioMedical Research- Dr. Christopher Howarth, Director of Staffing at Novartis
Moderated by: Pearl Freier, Managing Director Talent Capital Group
Pearl Freier is Managing Director of the Life Sciences Division of Talent Capital Group, a venture capital funded executive search firm in Cambridge. Freier works with clients ranging from pre-IPO early stage biotech companies to Fortune 500 corporations. She also contributes articles to Science Careers and Bio-IT World.com and gives workshops throughout North America for groups including the AAAS, the American Association for Pharmaceutical Scientists, and The Boston Globe. She currently sits on advisory boards for the New England Business and Technology Association (NEBATA) and the MIT Enterprise Forum of Cambridge.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Harvard Alumni Series: Dennis E. Vaccaro, Ph.D
|
| Date: |
Thursday October 9, 2003 |
| Description: |
Harvard Alumni Series
Join us for the inaugural event of the Harvard Biotechnology Club's new seminar series.
October 9th, 4 pm
Bldg C. Cannon Room
Harvard Medical School
Harvard DMS Alumnus and biotech enterpreneur Dennis E. Vaccaro, Ph.D., will lead an informal discussion about his successful transition from academia to industry.
Dr. Vaccaro is the founder of Symbiontics, a company exploring the use of protozoa to treat human disease, and BioPhysics Assay Laboratory, which develops new multiplex assay technology for the in vivo measurement of organ/system function. Dr. Vaccaro founded and is the co-chair of the Drug Discovery Committee of the Mass Biotech Council. He serves as the Chair of the DMS Alumni Association and is a member of the Harvard GSAS Alumni Council.
Before founding Symbiontics and BioPhysics Assay Laboratory, Dr. Vaccaro did his Ph.D. in the DMS Physiology Department (now systems biology) and did a postdoctoral fellowship in neuropathology at Children's Hospital.
After his postdoctoral work, Dr. Vaccaro joined NEN/DuPont where he held management positions in R&D, business planning, technical marketing and product management in both the diagnostic and research product areas of the company. He was then recruited to Advanced Magnetics where he helped to form the In vitro Diagnostics division and became its President. Spun off as PerSeptive Diganostics, this company focused on developing and marketing immunoassays for both research and clinical diagnostic uses. It also developed new magnetic separations technology used for cell sorting, human clinical diagnostics (where it created a multi-hundred million dollar business) and nucleic acid isolation.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Careers in Business Seminar Series: Whats it Worth? Forecasting the Future of Drugs and Markets
|
| Date: |
Thursday May 15, 2003 |
| Description: |
Careers in Business Seminar Series: Whats it Worth? Forecasting the Future of Drugs and Markets
Speaker:
Kevin Pang Ph.D., M.B.A.
Vice President
Decision Resources, Inc.
May 15, 2003
MEC Amphitheater
5:30 pm
Will a drug become a blockbuster? Why? Which diseases should biotechnology and pharmaceutical companies target? What drug targets are likely to be the most treatable and lucrative? Kevin Pang from Decision Resources, a Boston-based market strategy, business intelligence, and consulting firm, will discuss techniques used to answer these questions and discuss how they are used to generate strategic decision-making in the biopharmaceutical space. This type of analysis is a foundation for R&D and strategic planning, licensing, portfolio analysis, and financial investment. Dr. Pang will discuss how Decision Resources applies their approach to serve clients in each of these arenas.
Refreshments will be served. RSVP not required. Free to all Club members. |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Harvard Pharma Summit - Big Pharma: Re-inventing drug development for the 21st Century
|
| Date: |
Thursday May 1, 2003 |
| Description: |
* Big Pharma: Re-inventing drug development for the 21st Century*
Date: May 1, 2003
Time: 3:00 - 6:30pm
Location: Harvard Business School Spangler Auditorium
What will the Pharmaceutical Industry look like in 10 years? How will Pharma deal with the rising cost of new drug development while meeting the challenges of generic drug makers? The GSAS Harvard Biotechnology Club, in collaboration with the Harvard Business School Healthcare and Biotechnology Group, has organized the Harvard Pharma Summit entitled, Big Pharma: Re-inventing drug development for the 21st Century, to address these and other issues. We have invited executives from Roche, GlaxoSmithKline, Astrazeneca, Novartis, Merck, and Wyeth to discuss the strategies they are employing in the areas of new drug innovation and marketing, structuring alliances with biotech and other pharmaceutical companies, intellectual property implications, and technology transfer.
The financial analyst view of the state of the pharmaceutical industry will be presented by Meirav Chovav, managing director in the healthcare group of UBS Warburg.
Our distinguished industry speakers include:
1. Ronald Krall, Senior Vice President, Worldwide Development, GlaxoSmithKline.
2. Lee Babiss, Vice President, Division of Preclinical Research and Development, Roche.
3. Jacky Vonderscher, Vice President, Head of Drug Development at Novartis Institutes for Biomedical Research.
4. Bennett M. Shapiro, Senior Vice President of World Wide Licensing and External Research at the Merck Research Laboratories.
5. Glenn Gormley, Vice President of Clinical Development, AstraZeneca.
6. Orest Hurko, Assistant Vice President, Discovery Medicine, Wyeth
Roundtable discussions will be moderated by Noubar Afeyan and Nicholas Galakatos.
Free online registration begins monday at www.thebiotechclub.org/pharma/
This summit meeting is generously sponsored by: Flagship Ventures and MPM Capital |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
The GSAS Harvard Biotechnology Club 4th Annual $5K Business Plan Competition/VC roundtable
|
| Date: |
Tuesday April 29, 2003 |
| Description: |
10 Things VCs Hate About Bad Business Plans--The GSAS Harvard Biotechnology Club will kick-off its 4th Annual $5K Business Plan Competition with a Venture Capital roundtable of seasoned venture capitalists who will provide helpful hints and insider wisdom on how to write a successful business plan. The expert panel will also explore new developments and directions in biotech venture capital: emerging business models, new technologies, the investment climate and market conditions.
Speakers include:
VC PANEL
Paul M. Kelly, Ed.D., MBA
Managing Director, Zero Stage Capital LLC
Anupam Dalal, M.D.
Principal, Flagship Ventures
Monika A. Vnuk, M.D.
Associate, Oxford Bioscience Partners
Thomas Boehm, M.D.
Senior Associate, Techno Venture Management
MODERATOR
Steve London, J.D.
Partner, Brown Rudnick Berlack Israels LLP
This event is free and open to the public. Anyone interested in learning the basics about writing a successful business plan and the venture capital process is encouraged to attend, as well as more advanced individuals who wish to hear from some of the field leaders.
Refreshments and networking opportunities will be provided at the conclusion of the discussion.
VC Panel and Business Plan Competition generously sponsored by Brown Rudnick Berlack Israels LLP
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Careers in Business Seminar Series: Exploring the World of Biotech Consulting
|
| Date: |
Thursday April 3, 2003 |
| Description: |
Location: Harvard Medical School, Bldg. C Cannon Room
Time: April 3, 5:00 pm
Have you ever wondered how biotechnology companies begin to design a strategic business plan, raise capital, or protect their intellectual property rights? Consultants Skip Irving and Amanda Repp from Health Advances, a Boston based biotechnology and healthcare industry strategy firm, will lead a discussion about the ways consultants are providing solutions to these and other questions facing the biotechnology industry. If you are eager to learn more about healthcare industry, its evolving technologies, and the major issues in biotechnology consulting, then this seminar is for you!
Refreshments will be served. RSVP not required. Free to all Club members.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Second Annual Women in Biotechnology Roundtable TUESDAY MARCH 25th
|
| Date: |
Tuesday March 25, 2003 |
| Description: |
**Tuesday March 25th, Armenise (D2) Bldg Amp**
Female graduate students and post-doctoral fellows considering an alternative career will want to attend this moderated discussion with women working at an elite level in various areas of the biotechnology industry. Discussion topics will range from alternative career paths to balancing work and family, and audience questions will be addressed.
At this summer’s President’s Economic Forum, Biotechnology Industry Organization (BIO) Board Member Una Ryan, PhD, spoke in support of using vaccine research to reduce the costs of healthcare coverage for an aging and overweight U.S. population. Currently in Phase II clinical trials, a cholesterol management vaccine created by her company, AVANT Immunotherapeutics, has the potential to become a low cost prophylactic treatment for atherosclerosis. Also active in the bioterrorism arena, Dr. Ryan recently represented BIO in its effort to pass the Public Health Security and Bioterrorism Act of 2002, and licensed portions of AVANT’s platform of BioDefense Vaccines to the U.S. Department of Defense.
Alison Taunton-Rigby, PhD, brings twenty-five years of experience to her Director positions at the Massachusetts Biotechnology Council and the Massachusetts Women’s Forum. She is currently President and CEO of RiboNovix, Inc., a developing biotechnology company harnessing functional genomics to fight the growing problem of antibiotic resistance.
As President of Genzyme’s Molecular Oncology Division, Harvard Business School MBA Gail Maderis leads the company’s efforts to develop immunotherapeutic and antiangiogenic agents. The Division’s proprietary discovery platforms have been used to move a number of therapies into Phase I/II clinical trials.
Refreshments will be served. RSVP not required. Free to all Club members. |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
How Grad Students and Post Docs Can Start Their Own Biotech Companies & Make Piles of Money...
|
| Date: |
Tuesday November 5, 2002 |
| Description: |
Thomas Hemnes and Sharon Webb, M.D., Ph.D.
(Foley & Hoag)
How Grad Students and Post Documents can Start their own Biotech Companies, Make Piles of Money and Live Happily Ever After...
OK, now that we've got your attention, we've got some bad news for you. You know that great discovery you've been working on for years in the lab, the one that you're going to build your start-up around -- it's not yours. Don't worry, it's probably doesn't belong to anyone else in the lab either. It almost certainly belongs to your dear Alma Mater.
But the bad news isn't as bad as it seems. Truth is, for Harvard to succeed, she needs you to succeed. We'll offer you the inside knowledge you'll need to make your fortune and to get your piece of the action after slaving away all these years. All legal, fair and square -- and all without getting your Mother mad at you (or us). What more could you ask from a one hour talk???
See you there - and be ready to sign on the dotted line!
NO RSVP-Free to all Members-Dinner Provided |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Company Spotlight: Atherogenics: Academia and Biotechnology: A Paradigm of Value Creation
|
| Date: |
Thursday October 17, 2002 |
| Description: |
Academia and Biotechnology: A Paradigm of Value Creation
• Building a Biotechnology Company: What are the investment risks and challenges for entrepreneurs?
• Transitioning from Scientific Vision into Clinical Reality
• Value Creation and Risk Mitigation in Pharmaceutical Drug Development
• The Building Blocks of Biotechnology: Corporate Valuation
• Targeting Large Market Opportunities
• The Biotech Start-up Hurdles
Russell M. Medford, M.D., Ph.D. is scientific co founder, President and Chief Executive Officer of AtheroGenics (Nasdaq: AGIX), an Atlanta-based pharmaceutical company. Dr. Medford’s presentation, “Academia and Biotechnology: A Paradigm of Value Creation” reflects his first-hand entrepreneurial experience in transitioning from academia medicine into the business of biotechnology. AtheroGenics, founded in 1993, is focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases.
October 17th, 5:30 pm
HMS, Bldg D Amphitheater
No RSVP required. Free to all members. |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
423 Essential Pieces of Patent & Business Information for Biotech Start-ups (time permitting)
|
| Date: |
Wednesday September 25, 2002 |
| Description: |
Thomas M. Saunders
(Brown, Rudnick, Berlack & Israels, LLP)
Converting cutting edge science into a business requires the obligatory growth factor called money. Surprisingly, securing money does not depend heavily on the underlying science. Scientific entrepreneurs and BigPharma alike pursue only sound leads. Nevertheless, most new drugs, techniques, devices, and platforms fail. Your ideas face these same odds. While Brownian motion determines which ideas ultimately succeed, the physiology of business determines which are granted funding to potentially succeed.
This presentation will address:
-Patents, when you need them, what they cost, and how to fake it.
-Hints on prostituting yourself to venture capital.
-Why you can’t transfer science credits to the business world.
-Amusing mistakes you are likely to make.
No RSVP required. Free to all members. |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Company Spotlight: Sequenom-The Renaissance of Genetics
|
| Date: |
Monday September 9, 2002 |
| Description: |
Join us for a presentation from Sequenom, a leader in genotyping analysis. Three sessions will be offered covering their technology platform:
Accurate and High-Throughput Genotyping: The MassARRAY Technology
(30 minutes)
The MassARRAY system combines proprietary enzymatic reactions, a miniaturized SpectroCHIP, MALDI-TOF mass spectrometry and highly sophisticated bioinformatics software. Each of these components contributes to unparalleled performance in speed, accuracy, and cost.
Implementation of Discovery Genetics: Targeted SNP Discovery (30 minutes)
SNP Discovery is a new application for our high-throughput MassARRAY system. It is based on our MassCLEAVE technology, which generates sequence specific cleavage patterns from PCR amplicons. This allows for the detection of new polymorphic sites as well as bacterial or pathogen-typing, methylation pattern analysis and sequence verification for molecular diagnostics.
Growth, Innovation, Discovery: Sample Pooling (30 minutes)
SEQUENOM's internal genomics projects are fueled by a sample pooling technique called allelotyping, which has resulted in numerous SNP discoveries and publications. This technique confirms the presence of a SNP and its allelic frequency in a population using the MassARRAY system. With this technology, we will demonstrate the ability to analyze DNA pools of hundreds of individuals in a single reaction, allowing you to rapidly pre-evaluate SNPs, screen patient populations and significantly reduce your total workload for individual genotyping.
Presenters include:
Charles Cantor, Ph.D.
Chief Scientific Officer
Dirk van den Boom, Ph.D.
Director of Molecular Biology
Betsy Nanthakumar, M.Sc.
Associate Director of Automated Systems
Non-Pizza dinner and drinks will be provided. Registration is encouraged at: www.sequenom.com/seminar However, walk ins are also welcome. |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Biotech Venture Capital Roundtable
|
| Date: |
Wednesday May 15, 2002 |
| Description: |
The GSAS HARVARD BIOTECHNOLOGY CLUB PRESENTS its 2nd Annual Biotech VC Roundtable discussion.
This expert panel, representing three of the top biotech/bioscience venture capital firms in the country, will explore new developments, directions and perspectives on biotech venture capital: emerging business models, new technologies, the investment climate and market conditions.
This event is free and open to the public. Anyone interested in learning the basics about the venture capital process is encouraged to attend as well as more advanced individuals who wish to hear from some of the field's leaders.
Q/A session to follow discussion.
MODERATOR:
Jack Gill, PhD, founder/General Partner Vanguard Ventures, Harvard Medical School faculty
PANEL:
-Bryan Roberts, PhD, General Partner, Venrock Associates.
-Michael Lytton, General Partner, Oxford Bioscience Partners.
- Ed Kania,, Flagship Ventures
(NewcoGen Group, AGTC Funds, OneLiberty Funds)
For more information, please contact: kim@thebiotechclub.org |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
WOMEN IN BIOTECH CAREER FORUM
|
| Date: |
Tuesday April 30, 2002 |
| Description: |
Women interested in using their PhD outside of academia can't miss this event. High profile women from a variety of realms of the biotechnology field will discuss their career choices and provide advice for women considering alternative careers.
Panelists include Vicki Sato, Ph.D., President Vertex Pharmaceuticals; Katherine Call, Ph.D., Global Head, Genomics Technology Transfer, Aventis Pharmaceuticals; Leslie M. Levine, V.M.D., Ph.D.,J.D. Senior Vice President, Intellectual Property, Boston Life Sciences; Moderator: Monica Higgins, M.B.A., PhD., Assistant Professor, Harvard Business School |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Globalization of the Biotechnology Industry: Successful Transnational Cooperation
|
| Date: |
Thursday May 10, 2001 |
| Description: |
Panelists: Jonathan J. Fleming General Partner Oxford Bioscience Partners
Michael Steinmetz, PhD General Partner MPM Capital LP
Bernd Seizinger, Prof., Dr. CEO GPC Biotech
Alan Houston, MD CMO Variagenics Inc.
Neil P. DeAngelis Partner Ernst & Young LLP
Moderator: Cornelis H. Wortel, MD, PhD, President & CEO, ClinQuest Inc.
Details: 6:00 Registration
6:30 Panel Discussion
8:30 Reception/Dinner Buffet
Co-hosted with the German-American Business Council in collaboration with the British, French and Netherlands Chambers of Commerce
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Lion Biosciences: Information Integration - New Economy in Life Sciences
|
| Date: |
Tuesday April 3, 2001 |
| Description: |
LION bioscience aims to significantly and sustainably improve Life Science R&D performance and productivity through application and implementation of comprehensive and seamless information and knowledge management solutions that are based on a strong scientific basis andexperience. These solutions span and integrate all disciplines in R&D, starting from genetics over early and late discovery into clinics. LION offers these solutions to partners throughout the whole life science industry in basically two main ways:
1. i-biology: installation and implementation of an enterprise-wide horizontal information and knowledge management solution
2. iD3: internal application of i-biology to the own nuclear receptor discovery program with the goal to outlicense specific databases, polymorphism marker panels, and validated leads and targets.
Founded in 1997, the company today has more than 400 employees, with headquarters in Heidelberg, Germany, and subsidiaries in Cambridge, UK, Cambridge, MA, USA, and San Diego, CA, USA. To date, LION has established
numerous partnerships with leading Life Science companies, including Aventis,
Bayer, Boehringer Ingelheim, Celera, DuPont, Glaxo Wellcome, GMD, Janssen, Merck Inc., Nestlé, Novartis, Paradigm Genetics, Pharmacia & Upjohn, SmithKline
Beecham, Sumitomo Pharmaceuticals and Tripos.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Polaris Ventures presents: The Science and Business of Biotechnology
|
| Date: |
Monday January 1, 2001 |
| Description: |
The GSAS Harvard Biotechnology Club, in conjunction with Polaris Venture Partners (http://www.polarisventures.com), will be presenting a two-evening mini-symposium: The Science and Business of Biotechnology. The symposium will give a general overview of the business of Biotech from both a venture capital and a business model perspective, as well as delve into a case study of Microbia (http://www.microbia.com), a biotech company recently funded by Polaris.
Featured speakers include:
Terry McGuire, General Partner, Polaris Venture Partners
Josh Lerner, Professor, Harvard Business School
Peter Hecht, Founder and CEO, Microbia.
In addition, the Biotech Club will present tutorials on basic biology (3/27) and biotechnology (3/28). Advance registration required; see link above.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Company Spotlight: US Genomics
|
| Date: |
Tuesday May 23, 2000 |
| Description: |
U.S. Genomics (USG) is pioneering breakthrough technologies for direct, linear analysis of DNA for the global life sciences industry. Modeled after the cellular machinery used to read genetic material, the Company’s technologies have the potential to transform the commercial utility of genomic information by enhancing its quality and breadth of application. USG is focused initially on providing technology products and services to markets in drug discovery, pharmacogenomics, and diagnostics.
To address the emerging commercial need for the rapid production of usable and comprehensive genomic data, USG has created a fundamental new technology platform that allows direct, linear DNA analysis. Modeled after the natural method of reading genetic material during cell division, the Company’s technology platform greatly expands the read lengths for which DNA can be analyzed. USG’s technology theoretically has no upper limit on the length of DNA that can be read, a characteristic that offers the potential of transforming the utility and commercial application of genomic analysis.
Core Technologies
* GeneEngine™ Detection Technology – Complete hardware system to execute USG’s direct, linear readings of DNA. The system is designed to use the software of the DNA Delivery Mechanismä .
* DNA Delivery Mechanismä – Nanotechnology system for allowing DNA to be read linearly. The product includes software tailored to specific applications
* Genomics Database – A genomics and biological knowledge-based product that will serve as a resource for storing and mining valuable information
* Bioinformatics – Computational tools and software for the integration, analysis and management of genomic and biological information from internal and external data sources.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Harvard Biotechnology Club 2008 Career Fair
|
| Date: |
Wednesday November 11, 1998 |
| Description: |
Harvard Biotechnology Club¡¦s 2008 Career Fair will be held on November 11th this year, at the Rotunda in the New Research Building from 1-5pm. We will have two events leading up to the Career Fair:
**Harvard Biogen Idec Day, October 20, 12pm, Pechet Room at the New Research Building. (Please see above)
**2 back-to-back workshops on October 30, 2:30-4:30pm, Warren Alpert Building, room 341-65: ¡§CVs for Scientists for Non-Academic Jobs¡¨ and ¡§Networking at the HBC 2008 Career Fair¡¨. Please RSVP for this event at RSVP@thebiotechclub.org with the subject ¡§workshops¡¨.
If your company is interested in participating in the career fair this year, the deadline for early registration is October 13th, and the deadline for the regular registration is October 28th. Your company will also have the opportunity to host a 30-minute presentation at the career fair for our attendees. Please visit http://www.thebiotechclub.org/careerfair2008/employers.html for more information, including downloading the registration form. For questions, pleas! e email us at careerfair@thebiotechclub.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Harvard Biotechnology Club 2008 Career Fair at HMS
|
| Date: |
Wednesday November 11, 1998 |
| Description: |
Harvard Biotechnology Club's 2008 Career Fair will be held on November 11th this year, at the Rotunda in the New Research Building from 1-5pm. We will have two events leading up to the Career Fair:
Harvard Biogen Idec Day, October 20, 12pm, Pechet Room at the New Research Building. (Please see above)
2 back-to-back workshops on October 30, 2:30-4:30pm, Warren Alpert Building, room 341-65: *CVs for Scientists for Non-Academic Jobs* and *Networking at the HBC 2008 Career Fair*. Please RSVP for this event at RSVP@thebiotechclub.org with the subject *workshops*.
If your company is interested in participating in the career fair this year, the deadline for early registration is October 13th, and the deadline for the regular registration is October 28th. Your company will also have the opportunity to host a 30-minute presentation at the career fair for our attendees. Please visit http://www.thebiotechclub.org/careerfair2008/employers.html for more information, including downloading the registration form. For questions, pleas! e email us at careerfair@thebiotechclub.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Moving Your Career Forward in the Biotech and Pharmaceutical Industries
|
| Date: |
Tuesday October 27, 1998 |
| Description: |
Moving Your Career Forward in the Biotech and Pharmaceutical Industries This panel discussion will include scientific leaders and human resources staffing executives from companies including Alnylam, Genzyme, Sirtris, and Vertex Pharmaceuticals to discuss growth opportunities in the industry, employers' perspectives on what makes an attractive candidate, and suggestions for transitioning from academia to industry. Q&A period with the audience to follow the discussion .
*Please note – only pre-registered candidates are invited to attend. Please bring your confirmation number with you to the career fair before 12:30pm to attend. Space is limited, so please arrive early to ensure your attendance.
Confirmed panelists:
Rachel Meyers, PhD, Senior Director of RNAi Lead Development, Alnylam Pharmaceuticals Carolyn Churcher, Senior Director Strategic Staffing, Genzyme Corporation Brian M. Gallagher, Jr. PhD, Director of Strategic Development, Sirtris, a GSK company Lisa Anderson, Senior Director Strategic Staffing, Vertex Pharmaceuticals
For more information, please visit:
http://www.biospace.com/jobs/career-fair-detail/?CareerFairId=159
Moderated by: Pearl Freier, Cambridge BioPartners
Contact person: June Salvati, june.salvati@biospace.com |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Harvard Biogen Idec Day
|
| Date: |
Tuesday October 20, 1998 |
| Description: |
To give our members a chance to get to know Biogen Idec, one of our club sponsors, we will be hosting a Harvard Biogen Idec Day on October 20. This will be a 2-part event ¡V please see below for a tentative agenda. There is limited space so please RSVP for this event at RSVP@thebiotechclub.org with the subject "Biogen Idec," and indicate whether you would like to attend the HMS event, the Biogen Idec onsite event, or both.
12pm ¡V 3pm (HMS, at the Pechet Room in NRB):
Biogen Idec Keynote Speech will address topics such as what is a Biotech? Biogen Idec¡¦s product pipeline, and an overview of one of the therapeutic areas (Neurology, Immunology, Rheumatology, Oncology).
Informal networking lunch between Biogen Idec and HBC participants.
A panel discussion focusing on topics related to careers in biotech careers with Q&A session. Panel participants would be a mix of seasoned and junior Biogen Idec scientists.
4pm (Biogen Idec, onsite): Networking cocktail hour between Harvard students, Biogen Idec Harvard alums, and Biogen Idec event participants. Priority for this event will be given to Harvard-affiliated members. Please RSVP for this event at RSVP@thebiotechclub.org and include your name, affiliation and position at Harvard. We will not be organizing transportation from to Biogen Idec (14 Cambridge Center, Cambridge).
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Harvard Biogen Idec Day at HMS & Biogen Idec
|
| Date: |
Tuesday October 20, 1998 |
| Description: |
To give our members a chance to get to know Biogen Idec, one of our club sponsors, we will be hosting a Harvard Biogen Idec Day on October 20. This will be a 2-part event. Please see below for a tentative agenda. There is limited space so please RSVP for this event at RSVP@thebiotechclub.org with the subject "Biogen Idec," and indicate whether you would like to attend the HMS event, the Biogen Idec onsite event, or both.
12pm ¡V 3pm (HMS, at the Pechet Room in NRB):
*Biogen Idec Keynote Speech will address topics such as what is a Biotech? Biogen Idec¡¦s product pipeline, and an overview of one of the therapeutic areas (Neurology, Immunology, Rheumatology, Oncology).
*Informal networking lunch between Biogen Idec and HBC participants. A panel discussion focusing on topics related to careers in biotech careers with Q&A session. Panel participants would be a mix of seasoned and junior Biogen Idec scientists.
4pm (Biogen Idec, onsite): Networking cocktail hour between Harvard students, Biogen Idec Harvard alums, and Biogen Idec event participants. Priority for this event will be given to Harvard-affiliated members. Please RSVP for this event at RSVP@thebiotechclub.org and include your name, affiliation and position at Harvard. We will not be organizing transportation from to Biogen Idec (14 Cambridge Center, Cambridge).
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Harvard Biotech Club - Biogen Idec Day
|
| Date: |
Tuesday October 20, 1998 |
| Description: |
To give our members a chance to get to know Biogen Idec, one of our club sponsors, we will be hosting a Harvard Biogen Idec Day on October 20. This will be a 2-part event. Please see below for a tentative agenda. There is limited space so please RSVP for this event at RSVP@thebiotechclub.org with the subject "Biogen Idec," and indicate whether you would like to attend the HMS event, the Biogen Idec onsite event, or both.
12pm to 3pm (HMS, at the Pechet Room in NRB):
*Biogen Idec Keynote Speech will address topics such as what is a Biotech? Biogen Idec's product pipeline, and an overview of one of the therapeutic areas (Neurology, Immunology, Rheumatology, Oncology).
*Informal networking lunch between Biogen Idec and HBC participants. A panel discussion focusing on topics related to careers in biotech careers with Q&A session. Panel participants would be a mix of seasoned and junior Biogen Idec scientists.
4pm (Biogen Idec, onsite): Networking cocktail hour between Harvard students, Biogen Idec Harvard alums, and Biogen Idec event participants. Priority for this event will be given to Harvard-affiliated members. Please RSVP for this event at RSVP@thebiotechclub.org and include your name, affiliation and position at Harvard. We will not be organizing transportation from to Biogen Idec (14 Cambridge Center, Cambridge).
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
StartUp Opportunities in Life Sciences by Lyon Area Economic Development Agency (ADERLY)
|
| Date: |
Wednesday September 23, 1998 |
| Description: |
Join us at the workshop : "StartUp Opportunities in Life Sciences" on Tuesday September 23, 6:30pm
Meet with entrepreneurs, business coaches, representatives of the Lyon bio-cluster to :
- Figure out why and how to start a Tech Venture between the US and France/Europe,
- Get some testimonials by French-American bio entrepreneurs,
- Identify why Lyon ranks #1 in Life Sciences,
- Boost your start-up project with partners, resources and funding opportunities.
- A networking cocktail will follow the workshop .
For the full program and to register, or print the invitation attached to this email:
http://www.adgensite-emailing.com/aderly/newsletters/archives/tests/46/2008-07-25_15-39-41.html.
Hosted at the Genzyme Center, 500 Kendall St, Cambridge on tuesday September 23, from 6:30 to 8:30pm.
Presented by the Lyon Area Economic Development Agency (ADERLY), with the support of the French-American Chamber of Commerce (FACCNE) and the Young Entrepreneurs Initiative (YEi).
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Healthcare Consulting Panel Discussion
|
| Date: |
Thursday September 3, 1998 |
| Description: |
Harvard Biotechnology Club and the Consulting Club at MIT invite you to a
Healthcare Consulting Panel Discussion with Q/A
featuring
Clarion Healthcare Consulting
Clearview Healthcare Partners
Decision Resources
The Frankel Group
Health Advances
- Discover career opportunities at the intersection of science, technology, healthcare and business strategy
- Unique chance to learn about exclusively healthcare-focused consulting firms and get recruiting tips
- Hear from consultants about how healthcare consulting is distinct from other types of consulting
Time: Sept 3rd Thursday, 5:30 – 7:00pm
Location: Room 270 – Building 3 (Entrance on 77 Massachusetts Avenue)
MIT, Cambridge
http://whereis.mit.edu/map-jpg?zoom=level2¢erx=710029¢ery=495411&oldzoom=level3&map.x=300&map.y=183
HMS M2 shuttle drops off at 77 Massachusetts Avenue. For M2 shuttle schedule :
http://www.masco.org/transit/ptsM2_WeekdaySchedule.htm
Registration is not required but highly appreciated.
To register and for any questions regarding the event, please email rsvp@thebiotechclub.org
Dinner will be provided.
Panelist Bios
Steven Chao, Partner, ClearView Healthcare Partners
Steven has 10 years of experience in life science strategy consulting following MD/PhD program. He was most recently VP of Leerink Swann Strategic Advisors and prior to that a Manager at McKinsey and Company, where he led strategic and operations engagements in pharmaceuticals, biotechnology, and payer organizations. Steven has published over 20 articles, and was involved in Neuroscience research in the laboratories of Dr. Lawrence Benowitz and Dr. Jonathan Seidman. He received his BA in Biochemistry from Harvard College, and M.D. and Ph.D. in Neuroscience from Harvard Medical School.
Rob Stolper, Principal, Decision Resources
Robert is a Principal with the Consulting group at Decision Resources, where he has extensive experience in pharmaceutical strategy development, product life cycle planning, and market and technology analysis. Mr. Stolper's work includes later-stage clinical development and commercialization opportunity, as well as assessment of innovative drug development strategies, and spans all key therapeutic markets. He recently led an engagement exploring the opportunities and implications of innovative research in cell-based therapeutics for use in academic, commercial, and clinical settings, and developed set of recommendations for a leading global provider of enabling technologies to guide near- and long-term investments. Prior to Decision Resources, Mr. Stolper was a consultant with ISO Healthcare Consulting (part of Monitor Group), where he led product- and franchise-level strategy development engagements. Mr. Stolper received his A.B. in Biochemical Sciences from Harvard University.
Pushwaz Virk, Consultant, The Frankel Group
Pushwaz joined Frankel Group in 2008 as a Consultant. Since joining, he has worked on a variety of corporate, Technology and Commercialization strategy, Portfolio optimization and L,M&A projects including development of strategy for a Fortune 50 life sciences company to identify, evaluate and invest in early stage technologies, landscape assessment for a biologic in EU, development of M&A strategy for a startup etc. Prior to Frankel Group, Pushwaz was a Management Fellow at Harvard University Health Services and Group Health Plan where he worked on strategic and operational projects in Quality, Finance and Information Technology departments. He also conducted research on international healthcare delivery models at Harvard Business School and developed teaching content on medical tourism. Before joining Harvard, Pushwaz was the Business Development manager at HCL Technologies where he setup the life sciences and healthcare practice of the IT services division and medical process outsourcing business in the BPO division. He practiced as a primary care physician and hospital administrator before moving to the industry. Pushwaz has degree in medicine from Dayanand Medical College India, MBA from University of Delhi, and Masters in Public Health specializing in Healthcare Management from Harvard University.
Marie Schiller, Partner, Health Advances
Marie joined Health Advances in 1998 with extensive experience in the biotech industry. In Marie's more than one hundred client projects at Health Advances, she has focused on guiding management through business and scientific analyses regarding product development, market positioning, portfolio optimization, business development, and corporate strategy. Prior to joining Health Advances, Marie worked at ArQule, Inc. as production scientist in combinatorial chemistry, synthesis, and production. She also worked for GelSciences, Inc., as project scientist in Polymeric Drug Delivery Systems. Marie contributes extensive expertise in protein-based therapies, drug delivery systems, and several clinical areas, including diabetes and autoimmune diseases. Her clients range from early-stage biotech companies to large pharmaceutical companies. Marie graduated magna cum laude with a BA in chemistry from the University of Vermont, where she was also inducted into the Phi Beta Kappa honor society.
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
WOMEN IN BIOTECHNOLOGY PANEL
|
| Date: |
Monday June 1, 1998 |
| Description: |
The Harvard Biotech Club presents
WOMEN IN BIOTECHNOLOGY PANEL
Time: June 1st, 5-7pm (includes networking & dinner)
Location: Cannon Room, Harvard Medical School (
http://www.hms.harvard.edu/about/maps/quadmap.html
.- between C1-C2 link)
Come and meet distinquished women leaders in the biopharmaceutical
industries - from VC, to patent lawyer, to the executive team of
well-known biotech companies - and learn about how they made their
way to success, what they have learned, and how they have balanced
their personal lives with their careers. This year, we are very
excited about our stellar panelists that include venture capitalist,
patent lawyer, and executive leaders from biotech companies.
Speakers include
Ellen Baron: Partner, Oxford Biosciences
Carmen Bozic: Vice President, Biogen Idec
Teresa Compton: Executive Director, Novartis
Ivana Magovcevic-Liebisch: Executive VP, Dyax Pharmaceuticals
Moderatated by Pearl Freier, Cambridge BioPartners
Men are invited and welcome to attend!
This event is free to all students and postdoctoral fellows at Harvard or Harvard affiliated hospitals.
For non-Harvard affiliates, the entrance fee is $10 to be paid at the door.
For questions and to register, please email: rsvp@thebiotechclub.org
For more information about our club, please visit:
http://www.thebiotechclub.org
|
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
Women in Biotech
|
| Date: |
Monday June 1, 1998 |
| Description: |
The Harvard Biotech Club presents
WOMEN IN BIOTECHNOLOGY PANEL
Time: June 1st, 5-7pm (includes networking & dinner)
Location: Cannon Room, Harvard Medical School ( http://www.hms.harvard.edu/about/maps/quadmap.html.- between C1-C2 link)
Come and meet distinquished women leaders in the biopharmaceutical industries - from VC, to patent lawyer, to the executive team of well-known biotech companies - and learn about how they made their way to success, what they have learned, and how they have balanced their personal lives with their careers. This year, we are very excited about our stellar panelists that include venture capitalist, patent lawyer, and executive leaders from biotech companies.
Speakers include
Ellen Baron: Partner, Oxford Biosciences
Carmen Bozic: Vice President, Biogen Idec
Teresa Compton: Executive Director, Novartis
Ivana Magovcevic-Liebisch: Executive VP, Dyax Pharmaceuticals
Men are invited and welcome to attend!
This event is free for all students and all postdoctoral fellows working at Harvard/Harvard affiliated hospitals.
For non-Harvard affiliates, the charge is $10 to be paid at the door.
For questions, please email: rsvp@thebiotechclub.org
For more information about our club, please visit: www.thebiotechclub.org
|
| File Attachments: |
File (850_Women_in_Biotech_bios.doc)
JPEG(None)
PDF(None)
|
|
The Annual Women in Biotech Event
|
| Date: |
Monday June 1, 1998 |
| Description: |
The Harvard Biotech Club presents
WOMEN IN BIOTECHNOLOGY PANEL
Time: June 1st, 5-7pm (includes networking & dinner)
Location: Cannon Room, Harvard Medical School ( http://www.hms.harvard.edu/about/maps/quadmap.html.- between C1-C2 link)
Come and meet distinquished women leaders in the biopharmaceutical industries and learn about how they made their way to success, what they have learned, and how they have balanced their personal lives with their careers. This year, we are very excited about our stellar panelists that include venture capitalist, patent lawyer, and executive leaders from biotech companies.
Speakers include
Ellen Baron: Partner, Oxford Biosciences
Carmen Bozic: Vice President, Biogen Idec
Pamela Stetkiewicz: Executive Director, Novartis
Ivana Magovcevic-Liebisch: Executive VP, Dyax Pharmaceuticals
Men are invited and welcome to attend!
This event is free for all students and all postdoctoral fellows working at Harvard/Harvard affiliated hospitals.
For non-Harvard affiliates, the charge is $10 to be paid at the door.
To register, please email
rsvp@thebiotechclub.org
For more club information
www.thebiotechclub.org |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
"Getting the right message to the right ears" seminar event
|
| Date: |
Saturday April 25, 1998 |
| Description: |
If you choose a single person in the whole world to be on the other end of the line when the phone rings, and say, "tell me about your product or service," who would that person be? Why? When launching a new product or service, you will need to get the right people to hear your message and react. At the same time, you will have extremely limited time and limited budgets. The speaker will lead a discussion focused on how to get the message to the right people at the right time for the right results. This is will be an interactive presentation and will make use of many real-world examples, including how a small nanotechnology company with a potentially explosive product built a story that outpaced the competition, educated its audiences, and led to a full pipeline.
Speaker Bio:
Nicolas A. Boillot, President, Hart-Boillot, LLC
As co-founder of Hart-Boillot, Mr. Boillot has guided the agency to profitability in every year since it was founded in 1999. In his role as Account Director, he has managed significant communications campaigns for brands such as HP, Gore Bike Wear, EMC, Fairchild Semiconductor, Vicor and NanoHorizons. He has also worked in higher education as a teacher and in finance, where he analyzed European businesses for a group of American investors who sought acquisitions.
Registration is NOT required for this event! To help us out with expected numbers though, please let us know by signing up via this survey (it'll take 5 seconds!).
http://www.surveymonkey.com/s.asp?u=843043685865 |
| File Attachments: |
File (None)
JPEG(None)
PDF(None)
|
|
|
